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ABSTRACT 
RONG JIANG: Single Nucleotide Polymorphisms (SNPs) in Occupational Exposure 
Assessment 
(Under the direction of Leena A. Nylander-French) 
 
Significant individual variation exists in the systemic response to xenobiotic 
exposures that may be due to individual genetic differences in xenobiotic toxicokinetics, 
DNA-damage repair genes, host factors, and other environmentally responsive groups of 
genes and pathways.  The source of this variation may be dependent upon single nucleotide 
polymorphisms (SNPs), which may result in different levels of exposure biomarkers , tissue 
distribution and elimination, as well as heritable differences in physiological function (e.g., 
blood pressure, respiratory rate).  These individual genetic differences may directly or 
indirectly contribute to the associated health effects.  Our knowledge of individual 
differences in toxicokinetics and systemic response to xenobiotic exposures, genetic 
mechanism of associated health effects, and the potential value of incorporating individual 
genetic variations in exposure assessment models is limited.  I sought to investigate 
individual differences in SNPsassociated with skin naphthyl-keratin adducts (NKAs) and 
urine naphthol levels measured in workers exposed to jet propulsion fuel-8 (JP-8) containing 
naphthalene.  The SNP association analysis was conducted in PLINK using candidate-gene 
and genome-wide analyses.  I further determined the relative contributions of SNP markers 
and the impact of personal and workplace factors on the measured biomarker levels using 
multiple linear regression models.  Pathway and network analyses of the genetic variants 
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identified indicated significant associations with genes involved in the regulation of cellular 
and homeostasis processes that contributed to the observed level of skin NKAs.  Urine 
naphthol levels were associated with genes involved in thyroid hormone pathways and the 
control of metabolism that may affect the mass movement of naphthalene and its metabolites 
into the cells of tissues with the capacity to metabolize and eliminate xenobiotics.  I report 
here a method and strategy to investigate the role of individual genetic variation in the 
quantitative assessment of biomarker levels in small well-characterized exposed worker 
populations.  These tools have the potential to provide biological relevance on the biomarker 
levels, mechanistic insight into the etiology of exposure related diseases, and identification of 
susceptible subpopulation with respect to exposure.  Therefore, these tools will provide 
useful input into setting exposure limits by taking into account individual genetic variation 
that may relate to adverse health effects. 
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CHAPTER 1.  BACKGROUND AND SIGNIFICANCE 
1.1 Jet-propulsion fuel 8 (JP-8), its use and exposure 
JP-8, a kerosene-based fuel and distilled from crude oil, is a complex mixture of more 
than 228 aliphatic and aromatic hydrocarbons (Egeghy et al. 2003; IARC 1989; Irwin 1997).  
It is the predominant fuel used by U.S. military for aircrafts and land-based vehicles since 
1992, and used by militaries of some North Atlantic Treaty Organization (NATO) countries 
since 1972 (ATSDR 1998; Carlton and Smith 2000; NRC 2003; Zeiger and Smith 1998).  JP-
8 has a higher flash point and a lower vapor pressure than the previous aviation fuel (JP-4), 
which makes it much safer to handle.  Therefore, JP-8 has completely replaced JP-4 in the 
U.S. Air Force during the period of 1976-1996.  JP-8 consists of approximately 81% 
aliphatic hydrocarbons (primarily C9 to C16) and 19% aromatic hydrocarbons, including 
benzene (<0.02%) and naphthalene (average of 0.18%) (ATSDR 1998; Carlton and Smith 
2000; NRC 2003; Zeiger and Smith 1998).  In the U.S., JP-8 is the battlefield fuel for all U.S. 
military operations and is expected to be in use well beyond the year 2025 (Henz 1998).  The 
U.S. Department of Defense uses JP-8 at a rate of 3.5 billion gallons yearly and the U.S. Air 
Force is the largest consumer.  The U.S. Department of Defense recognizes JP-8 as the single 
largest source of chemical exposure for its personnel (Carlton and Smith 2000). 
The exposure to JP-8 occurs through inhalation of vapors and aerosols or direct 
contact with the skin.  Inhalation has been considered the main route of JP-8 exposure in 
many studies, but the risk of dermal exposure is high since maintenance personnel wear only
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cotton garments during work (to prevent the buildup of static electricity).  In addition, the 
transition from the highly volatile JP-4 to JP-8 is believed to have contributed to the 
increased potential for dermal exposures (Ritchie 2001).  In comparison to its predecessors 
JP-4 and JP-5, JP-8 has a relatively low vapor pressure.  As a result, the potential for 
inhalation exposure to JP-8 is reduced, but dermal exposure is possibly increased (Lin et al. 
2004).  The National Research Council concluded that inhalation of JP-8 vapors does not 
present a carcinogenic risk but dermal exposure may present a risk for skin cancer and 
sensitization (NRC 2003). 
Field studies of JP-8 use on military bases have identified sources of exposure as 
spills during transportation and storage of fuel, fueling, general maintenance and operation of 
aircrafts, cold engine starts, and performance testing (NRC 2003).  JP-8 has been recognized 
as the major source of chemical exposure for fuel-cell maintenance workers.  Fuel-tank 
maintenance entrees had higher exposure to JP-8 than non-entrees via both dermal (Chao et 
al. 2005) and inhalation routes (Rhodes et al. 2003).  These persons enter aircraft fuel tanks 
to perform inspections and maintenance activities.  They are exposed to residual fuel in the 
tanks and exposed to fuel released from reticulated polyurethane foam (Rhodes et al. 2003).  
The whole body dermal exposure level was significantly higher (P < 0.0001) in the entrant 
groups [8.34 ± 2.23 ln(ng/m
2
)] than non-entrant (attendants and runners) group [6.18 ± 1.35 
ln(ng/m
2
)] (Chao et al. 2005). 
Although the Occupational Safety and Health Administration (OSHA) has not 
developed a permissible exposure limit (PEL) for JP-8, the U.S. Air Force has adopted an 8-h 
time-weighted average (TWA) occupational exposure limit of 350 mg/m
3
 and a 15-min 
short-term exposure limit (STEL) of 1800 mg/m
3
 (Rhodes et al. 2003).  Fuel tank entry 
3 
 
personnel were observed to have a TWA exposure as high as 1304 mg/m
3
 and a STEL of 
10,295 mg/m
3
 (Carlton and Smith 2000). 
1.2 Health effects 
In humans, major symptoms and health effects reported associated with JP-8 include 
mental fatigue, headache, and nausea (Smith et al. 1997), neurobehavioral changes (Smith et 
al. 1997; Zeiger and Smith 1998), neurocognitive changes (Tu et al. 2004), psychiatric 
disorders (Knave et al. 1976; Mindus et al. 1978; Struwe et al. 1983), posture balance 
problem (Smith et al. 1997), effects on reproductive (Reutman et al. 2002) and immune 
systems (Rhodes et al. 2003), skin irritation (Serdar et al. 2004; Serdar et al. 2003a), 
carcinogenesis (Brandt et al. 1999; Broddle et al. 1996; Parent et al. 2000; Siemiatycki et al. 
1987) and hematopoiesis (Abraham 1996; O'Connor et al. 1999).  Genotoxic changes 
(Lemasters et al. 1997), postural balance deficiencies (Kaufman 1998; Smith et al. 1997), 
hearing loss (Kaufman 1998), and female hormonal changes (Reutman et al. 2002) have been 
observed in the U.S. aircraft maintenance workers exposed to jet fuel.  Health effects related 
to psychiatric symptoms, attention deficits, and sensory-motor effects among Swedish 
workers exposed to jet fuel have also been reported (Knave et al. 1979; Knave et al. 1978; 
Knave et al. 1976).  Long-term skin contact with kerosene (the base mixture of JP-8) has 
been shown to increase the incidence of skin cancer in mice (NTP 1986). 
1.3 Naphthalene as a marker of JP-8 exposure 
Assessing exposures to JP-8 has been difficult due to the complex composition of this 
mixture.  Several components of JP-8, including the C9 to C12 n-alkanes, benzene, styrene, 
toluene, and naphthalene have been analyzed as possible surrogates in samples of air and 
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breath (Carlton and Smith 2000; Egeghy et al. 2003; Pleil et al. 2000; Puhala 1997).  
Naphthalene is one of prevalent constituent of JP-8 and was one of the most readily absorbed 
components of JP-8 in rat skin (McDougal et al. 2000; McDougal and Robinson 2002).  
Therefore, naphthalene could be a good surrogate for JP-8 exposure via dermal exposure 
route.  The use of naphthalene as a marker of dermal exposure to JP-8 has been investigated 
(Baynes et al. 2001; Chao et al. 2005; Chao et al. 2006; Chao and Nylander-French 2004; 
Kanikkannan et al. 2001a; Kanikkannan et al. 2001b; McDougal et al. 2000; McDougal and 
Robinson 2002; Riviere et al. 1999).  Specific naphthyl-keratin adducts have been quantitated 
in the skin of workers exposed to JP-8 (Kang-Sickel et al. manuscript; Kang-Sickel et al. 
2008; Kang-Sickel et al. 2010).  Naphthalene (or its metabolites) is also commonly used as a 
marker for exposure in urine and blood samples (Chao et al. 2006; Serdar et al. 2004; Serdar 
et al. 2003a; Waidyanatha et al. 2004).  The Occupational Safety and Health Administration 
(OSHA) has established an 8-h TWA permissible exposure level for naphthalene of 10 ppm 
(50 mg/m
3
) and a STEL of 15 ppm (79 mg/m
3
) (NTP 2000). 
1.4 Individual genetic variations 
1.4.1 Types of human genetic variations 
Human genetic variations include single nucleotide polymorphisms (SNPs), copy 
number variations (CNVs), and epigenetics, and they can occur at all scales.  A SNP is a 
DNA sequence variation occurring when a single nucleotide — A, T, C, or G — in the 
genome differs between members of a population.  A copy number variant (CNV) is a 
segment of DNA in which copy-number differences have been found by comparison of two 
or more genomes.  The segment may range from one kilobase to several megabases in size 
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(Cook and Scherer 2008).  Humans ordinarily have two copies of each autosomal region, one 
per chromosome. This may vary for particular genetic regions due to deletion or duplication.  
Another type of genetic variation that goes beyond differences in DNA sequence is 
epigenetics.  This type of variation arises from chemical tags that attach to DNA and affect 
how it gets read.  The chemical tags, called epigenetic markings, act as switches that control 
how genes can be read (NIH 2010).  Epigenetics is the study of inherited changes in 
phenotype or gene expression caused by mechanisms other than changes in the underlying 
DNA sequence. 
1.4.2 Single nucleotide polymorphisms (SNPs) 
For a variation to be considered to be a SNP, it usually occurs in at least 1% of the 
population (Chung et al. 2010).  Within a population, SNPs can be assigned a minor allele 
frequency, i.e., the lowest allele frequency at a locus that is observed in a particular 
population.  There are variations between human populations and, thus, a SNP allele that is 
common in one geographical or ethnic group may be rare in another group.  Most of SNPs 
are non-functional but some are functional and influence phenotypic differences between 
humans through alleles.  Build 131 of NCBI dbSNP released in 2010 contains over 23 
million SNPs in humans, of which 14.6 million are validated 
(http://www.ncbi.nlm.nih.gov/SNP/snp_summary.cgi). This is vastly more than enough 
variation to ensure individual uniqueness at the DNA level, but still represents a very small 
fraction of the total genome (human genome has about 3 billion nucleotides).  Most of this 
variation occurs in DNA of no known function, but common variants also occur in coding 
regions of genes, altering amino acid sequences of proteins, and in regulatory regions that 
affect gene expression (Tishkoff and Kidd 2004). 
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SNPs may be changed (substitution), removed (deletions), or added (insertion) to a 
polynucleotide sequence.  Insertion or deletion SNP (InDels) may shift translational frame 
(Vali et al. 2008; Vignal et al. 2002; Yue and Moult 2006).  SNP may fall within the coding 
sequence of a gene, the non-coding region of a gene, or in the intergenic region between two 
genes.  SNP within a coding sequence will not necessarily change the amino acid sequence of 
the protein that is produced, due to degeneracy of the genetic code.  A SNP in which both 
forms lead to the same polypeptide sequence is termed synonymous (sometimes called a 
silent mutation) — if a different polypeptide sequence is produced that is nonsynonymous.  A 
nonsynonymous change may either be missense or nonsense.  A missense change results in a 
different amino acid while a nonsense change results in a premature stop codon.  SNP that is 
not in protein-coding region may still have consequence for gene splicing, transcription 
factor binding, or the sequence of non-coding RNA. 
1.4.3 SNP genotyping microarray 
SNP genotyping methods include hybridization-based method (i.e., Affymetrix 
Genome-wide Human SNP array 6.0), enzyme-based method such as TaqMan assay 
(McGuigan and Ralston 2002), and other post-amplification methods based on physical 
properties of DNA including single strand conformation polymorphism (Costabile et al. 2006; 
Orita et al. 1989) and denaturing high-performance liquid chromatography (Oefner and 
Underhill 1995; Suh and Vijg 2005).  SNP microarray is one of the hybridization-based 
methods.  In high-density oligonucleotide SNP arrays, hundreds of thousands of probes are 
arrayed on a small chip, allowing for many SNPs to be interrogated simultaneously (Rapley 
R. 2004).  Because SNP alleles only differ in one nucleotide and because it is difficult to 
achieve optimal hybridization conditions for all probes on the array, the target DNA has the 
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potential to hybridize to mismatched probes.  This is addressed somewhat by using several 
redundant probes to interrogate each SNP.  Probes are designed to have the SNP site in 
several different locations as well as containing mismatches to the SNP allele.  By comparing 
the differential amount of hybridization of the target DNA to each of these redundant probes, 
it is possible to determine specific homozygous and heterozygous alleles (Rapley R. 2004).  
Although oligonucleotide microarrays have a comparatively lower specificity and sensitivity, 
the scale of SNPs that can be interrogated is a major benefit.  The Affymetrix Human SNP 
6.0 GeneChip performs a genome-wide assay that features ~1.8 million genetic markers, 
including more than 906,600 SNPs and more than 946,000 invariant probes for the detection 
of CNV (Affymetrix 2010). 
In this study, we used Affymetrix Human GeneChip 250K StyI array to genotype 
SNPs for workers exposed to JP-8.  Affymetrix 250K StyI array can be used to genotype 
~238,000 SNPs genome-wide for each worker.  Total genomic DNA (250 ng) is digested 
with StyI restriction enzyme and ligated to adaptors that recognize the cohesive four base-
pair (bp) overhangs.  All fragments resulting from restriction enzyme digestion, regardless of 
size, are substrates for adaptor ligation.  A generic primer that recognizes the adaptor 
sequence is used to amplify adaptor-ligated DNA fragments.  PCR conditions have been 
optimized to preferentially amplify fragments in the 200-to-1,100 bp size ranges.  The 
amplified DNA is then fragmented, labeled, and hybridized to a GeneChip Human Mapping 
250K Array.  Figure 1.1 illustrates hybridization and image generation.  Affymetrix 
Genechip® uses 25mer oligonucleotide probes corresponding to a perfect match (PM) and a 
mismatch (MM) for both allele A and allele B of a known SNP, yielding four different 
probes – PMA, PMB, MMA, and MMB.  This probe quartet is the basic unit for detecting 
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different genotyping groups: AA, AB or BB.  The genotype calling is to map the 
hybridization intensities of the quartets to a genotype call for each SNP represented on the 
array.  Highly accurate and reliable genotype calling is an essential component of any high-
throughput SNP genotyping technology.  Currently, several genotype calling algorithms have 
been used for Affymetrix SNP arrays, such as Dynamic Model (DM), Robust Linear Model 
with Mahalanobis distance (RLMM) (Rabbee and Speed 2006), Bayesian Robust Linear 
Model with Mahalanobis distance (BRLMM) (Affymetrix 2006), and Corrected Robust 
Linear Model with Maximum Likelihood Distance (CRLMM) (Carvalho et al. 2007).  Each 
algorithm has its own benefits and drawbacks.  BRLMM evolved from RLMM and performs 
a multiple-chip analysis fitting probe effects to increase precision on signal estimates for the 
two alleles of each SNP (Affymetrix 2006).  The first step of BRLMM is to normalize the 
probe intensities and summarize allele signal estimates.  In the meantime, DM derives an 
initial estimate of genotypes for each SNP.  A subset of SNPs is obtained across SNPs based 
on the allele signal estimates and initial genotyping seeds and a prior distribution for typical 
genotype region is derived.  Each SNP is then visited and its genotyping regions re-calibrated 
using an ad hoc Bayesian procedure to make a better genotype calls. 
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Figure 1.1 Illustration of hybridization and image generation in Affymetrix Human 
GeneChip array (image courtesy of Affymetrix). 
 
We used BRLMM algorithm as our genotype calling method because: (1) BRLMM 
performs a multiple chip analysis enabling the simultaneous estimation of probe effects and 
allele signals for each SNP (Affymetrix 2006); (2) the estimation of genotypes in BRLMM is 
a multiple-sample classification, which borrows information as necessary from other SNPs 
and enables to capture similarities across probes and SNPs to better predict the properties of 
the underlying clusters (Affymetrix 2006); (3) BRLMM does not depend on training data as 
initial clusters of genotypes (Affymetrix 2006; Xiao et al. 2007); (4) BRLMM equalizes the 
performance of heterogeneous and homogeneous genotypes (Affymetrix 2006); (5) the call 
rates and accuracy of BRLMM  are validated by Affymetrix; and (6) the application tool of 
BRLMM is readily available to investigators. 
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1.5 SNP association studies 
1.5.1 Candidate gene and genome-wide SNP association studies 
SNPs in human genome can affect how humans develop diseases and respond to 
chemicals, drugs, pathogens, and other agents.  In order to discover SNP allele variants that 
may contribute to a variation in a quantitative phenotype under investigation, an association 
study can be performed to examine phenotype variation against a SNP variation in a large 
unrelated population.  Based on the range of SNPs examined, candidate-gene or genome-
wide association study can be applied.  Candidate-gene approach focuses on SNPs on the 
genes that are selected because of a priori hypotheses about their role in the given phenotype, 
while genome-wide association study focuses on the influence of SNPs on the genes 
throughout the whole genome.  Candidate-gene association study has more power due to the 
known or inferred functions of particular gene(s) compared to genome-wide association 
study, which rely on markers that are spaced throughout the genome without regard of their 
function or context in a specific gene (Tabor et al. 2002).  A candidate-gene study, which 
may involve hundreds to thousands of genes participating in the same and different pathways 
in interaction with environmental factors, would be the first step in uncovering the genetic 
determinants of complex disease (Suh and Vijg 2005).  The technology of high-throughput 
microarrays has developed very dramatically and can identify large number of SNPs in the 
human genome with low cost.  For example, Affymetrix Genome-wide Human Array 6.0 has 
906,600 SNPs available for genotyping.  This provides the unprecedented opportunity to 
conduct genome-wide association studies among unrelated to subjects to examine the 
correlation between SNP allele and a complex disease. 
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1.5.2 Challenges in SNP association studies 
The statistical analysis of genome-wide data poses particular challenges because of 
the potentially huge numbers of statistical tests and, therefore, the high number of false 
positives (type I error).  The threshold for discovery of a genetic variant associated with a 
disease has been established at a high level (P-values between 5 × 10
-7
 – 1×10-8), known as 
genome-wide significance (Chung et al. 2010), to reduce the probability of a false-positive 
finding (O'Berg 1980; Wolff et al. 1993). Caution is required in determination of the power 
required to detect effect sizes expected to be observed based upon the study design.  
Generally, the susceptibility alleles discovered are common and each allele confers a small 
contribution to the overall risk for the complex disease like cancer.  For nearly all regions 
conclusively identified by genome-wide association study, the per allele effect sizes 
estimated are odds ratios <1.5 (Hindorff et al. 2009).  The mechanism by which these genetic 
variations have their effect on phenotype is far from obvious (Lee et al. 2006; Rioux et al. 
2001; Yue and Moult 2006).  However, the use of genome-wide significance threshold 
makes few SNPs exceed the stringent statistical requirement and leaves many SNPs with 
small measurable genetic effects out and sometimes causes type II error.  One example is the 
PPARG variants in type 2 diabetes, which was overlooked by four out of five studies 
(Altshuler et al. 2000; Baranzini et al. 2009).  Furthermore, association of complex traits such 
as disease status to an individual SNP is typically occluded by the large magnitude of other 
effects (Lee et al. 2006), such as environmental exposure, lifestyle, gene-environment 
interaction, and gene-gene interaction (Chung et al. 2010).  Identifying the gene-environment 
interactions will be difficult in genome-wide association study given the low prevalence of 
exposures in large, often multicenter epidemiological studies.  The study of interactions 
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between environment, individual genetic susceptibility, and the biological outcome 
(phenotype) in occupational exposure studies may, thus, provide a way to identify of gene-
environment interactions as the exposure is more prevalent and assessed with greater 
accuracy in well-characterized samples than is usually a case in population or hospital-based 
case-control studies, which have been commonly conducted in genome-wide association 
studies to date (Vlaanderen et al. 2010). 
1.5.3 Intermediate quantitative trait in SNP association analysis 
One approach to address the difficulty of SNP discovery contribution to a complex 
disease is to focus on the intermediate trait between genotype and phenotype.  Current 
association studies are focused on genetic variation and disease endpoints, i.e., either an 
effect is observed or not.  A number of recent studies have shown that it may be more 
informative to map intermediate steps in disease processes (i.e., intermediate phenotypes), 
such as various disease-related clinical traits or expression levels of genes of interest, rather 
than merely the binary case/control disease status, to genetic marker loci (Chen et al. 2008; 
Emilsson et al. 2008; Keller et al. 2008; Kim and Xing 2009; Kim et al. 2006).  These 
intermediate traits provide detailed insight to the relationship between genetic variations and 
disease phenotype because they are more directly influenced by the genetic variations.  
Misclassification in case-control status exists widely in epidemiology studies, which directly 
brings biases into the results.  Meanwhile, the use of binary outcome decreases the resolution 
of the association substantially since large variability in outcome is not captured using 
dichotomous case-control variables, especially in an exposure assessment study.  
Quantitative traits are more objective than categorical disease outcome in case-control study, 
and can increase the statistical power four to eight fold and, therefore, greatly decrease the 
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required sample size to obtain sufficient statistical power (Potkin et al. 2009a; Potkin et al. 
2009b).  The systemic exposure levels (parent compound or metabolite levels of xenobiotics) 
may be used as intermediate quantitative traits when investigating association between dose-
response relationship and individual susceptibility to disease to improve the resolution 
compared to only using binary disease outcomes. 
1.6 Biological function analysis 
1.6.1 SNP associated gene 
SNP association analysis will identify the significant SNPs associated with 
quantitative traits among exposed subjects.  Functional studies are needed to test whether 
associated SNPs alter the structure or functions of DNA, RNA, or proteins and affect the 
phenotypes.  Functional SNPs might alter peptide sequences, transcription factor binding 
sites and exon splicing enhancer/suppressor sites.  The biological relevance analysis of these 
SNPs will help us understand functional and regulatory status of associated sequences and 
genes, and make it biologically meaningful.  The curated sequence identification, location, 
and functions can be established using NCBI Entrez Gene (http://www.ncbi.nlm.nih.gov/snp), 
Ensemble BioMart (http://www.biomart.org), and UCSC gene browser 
(http://genome.ucsc.edu/). 
1.6.2 Gene network prediction and validation 
Network interactions were identified by MetaCore (GeneGo.com) and corroborated 
by literature analysis of the predicted associations and statistically predicted network 
interactions.  It will help to identify gene ontology enriched cell and biological processes and 
likely associations with the phenotype interrogated.  Network analysis not only can tell us 
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whether the identified significant SNP associated genes interact with each other, but also can 
predict what pathways and function they work together in the response to xenobiotic 
exposure.  While individual genetic effects are difficult to ascertain due to type I and type II 
errors, they can be collectively identified by combining nominally significant evidence of 
genetic association with current knowledge of biological pathways (Baranzini et al. 2009).  
GO is based on a library that consists of gene profiles that are associated with biological 
processes (Consortium 2001).  Gene sets identified with SNP microarray experiments are 
tested for their association with a profile in the GO library (Khatri and Draghici 2005).  In 
pathway analysis, not only the profile of genes associated with a specific biological process 
is tested, but also the functional interactions between genes in a profile (Draghici et al. 2007).  
Each new study will contribute to build a base of knowledge necessary for these types of 
analyses since there are large gaps still in knowledge of biological pathways (Vlaanderen et 
al. 2010).  Genomatix TransFac can be used for identifying potential transcriptional factor 
binding sites for gene promoter sequences identified by the network interaction analysis.  
Ultimately, the relationship has to be functionally established by genetic and molecular 
analysis. 
1.7 Individual genetic variations in exposure assessment 
1.7.1 Individual genetic variations in response to xenobiotic exposure 
Individual genetic variations exist in the absorption, distribution, metabolism, and 
elimination (ADME or toxicokinetics) of xenobiotics, DNA-damage repair genes, host 
factors, and other environmentally responsive groups of genes and pathways, etc. (Christiani 
et al. 2008).  Consequently, individual genetic variations may significantly contribute to the 
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variation observed in the levels of systemic exposure (i.e., urine and blood biomarkers) to 
xenobiotics and various stages of disease development (Christiani et al. 2008).  The source of 
variation may be dependent upon SNPs, CNV, and hyper- or hypomethylation patterns in 
gene coding region or in their regulatory control sequences (locus-control regions, promoter, 
introns, etc.) that may affect expression (transcript and protein) and function critical to 
xenobiotic toxicokinetics and maintenance of homeostasis.  These individual genetic 
differences may lead to differences in the levels of metabolites (e.g., urine, blood, or skin 
adducts), tissue distribution and elimination, as well as heritable differences in physiological 
function (blood pressure, heart rate, respiratory rate, etc.) that indirectly contribute to 
differences in associated health effects (resistance or susceptibility to disease).  However, 
individual genetic variations are not accounted for in current exposure and risk assessment 
models, which may significantly affect or confound exposure and risk assessment.  Our 
knowledge of individual differences in toxicokinetics of xenobiotic exposures, genetic 
mechanism of toxicity and associated health effects, and the impact of individual genetic 
variations in exposure assessment models is limited. 
1.7.2 Individual genetic variations in JP-8 exposure 
The major metabolic pathways of naphthalene are shown in Figure 1.2 (Waidyanatha 
et al. 2004).  After exposure, some of naphthalene is eliminated unchanged in the breath or 
urine.  However, most of the naphthalene is metabolized by cytochrome P450 isoenzymes 
(CYPs) to naphthalene-1,2-oxide, which can either rearrange to 1- or 2-naphthol excreted in 
urine, or be subsequently metabolized to 1,4-naphthaquinone and 1,2-naphthaquinone, 
respectively, that can form adducts with DNA and proteins.  Various enzymes are involved in 
the metabolism of naphthalene such as CYPs and glutathione-S-transferases (GSTs).  CYPs 
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are biotransformation phase I enzymes, which catalyze the metabolism of PAHs in human 
cells.  GSTs are biotransformation phase II enzymes, which can catalyze the conjugation of 
PAH diolepoxide metabolites with reduced glutathione (detoxification).  The variations in 
these enzymes may lead to different levels of systemic exposure of naphthalene and other 
PAHs upon JP-8 exposure and, consequently, contribute to the development of occupational 
disease.  
 
 
Figure 1.2 Major metabolic pathways of naphthalene [adapted from Waidyanatha et al. 
(Waidyanatha et al. 2004)]. 
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Individual genetic variations in the genes have been suggested to explain inter-
individual differences in the rate of metabolism and activation/detoxification of PAH-derived 
carcinogens (Alexandrie et al. 2000).  CYP2E1 and GSTM1 have been reported to play an 
important role in metabolism of naphthalene among coke oven workers (Nan et al. 2001).  
Urinary 2-naphthol concentrations were higher in worker with c1/c2 or c2/c2 genotype of 
CYP2E1 than those with c1/c1 genotype.  The levels of 2-naphthol were also higher in 
GSTM1 null workers than in GSTM1 positive workers.  CYP1A1*2 allele has been 
considered as a risk marker for PAH-related cancers associated with occupational exposure 
due to its greater capacity to activate PAHs (Lee et al. 2001; Nerurkar et al. 2000).  Multiple 
regression analysis of CYP1A1, CYP2E1, GSTM1, and GSTT1 on the level of urinary 2-
naphthol in aircraft maintenance workers showed that CYP1A1, GSTM1, and smoking were 
significantly associated with increased urinary 2-naphthol levels while none of them were 
significant among non-smokers (Lee et al. 2001).  Mixed-function oxygenases have been 
shown to be expressed in the liver during the metabolism of PAH, e.g., CYP1A1 (Kim et al. 
2004; Lee et al. 2001), CYP1A2 (Castorena-Torres et al. 2005; Kim et al. 2004), CYP1B1 
(Kim et al. 2004), CYP2E1 (Farin et al. 1995; Nan et al. 2001), CYP3A5 (Gabbani et al. 
1999; Piipari et al. 2000) as well as conjugating enzymes, such as GSTM1 (Gabbani et al. 
1999; Godschalk et al. 2001; Lee et al. 2001; Nan et al. 2001).  The expression of various 
genes related to antioxidant responses and detoxification, including those for GST and CYP 
proteins, were upregulated after exposure to JP-8 (Espinoza et al. 2005). The functional 
status of these enzymes and their relative contribution to the metabolites may be critical to 
the understanding of individual variations in responses to JP-8 exposure.  In addition to these 
metabolic enzymes, other gene expressions in regulatory region were altered after exposure 
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to JP-8.  For example, genes involved in basal transcription and translations were upregulated 
in human epidermal keratinocytes, whereas genes related to DNA repair were mostly 
downregulated (Chou et al. 2006).  Genes coded for growth factors, apoptosis, signal 
transduction, and adhesion were also altered (Chou et al. 2006). 
1.7.3 Significance of investigation of individual genetic variations in exposure 
assessment 
Current studies have shown that the interactions between genetic and environmental 
factors are critical to disease risk (Christiani et al. 2008; Vineis et al. 2009).  Therefore, the 
direction of research in this area should be towards investigating the genetic basis of 
individual susceptibility to the exposure of various environmental hazards.  Sources of 
individual genetic variations are not accounted for in the current exposure assessment studies.  
Investigation on contribution of individual genetic variations to systemic exposure and 
biomarker levels of xenobiotic exposure may provide mechanistic insight into the etiology of 
disease (Christiani et al. 2008).   Furthermore, inclusion of the individual genetic variations 
in exposure assessment models may allow us to identify a susceptible subpopulation with 
respect to workplace exposure, and provide useful input in setting exposure limits by taking 
into account individual susceptibility to adverse health effects in the occupational 
environment (Vineis et al. 1999).  Thus, it is important to investigate the role of individual 
genetic differences as potential modifiers in exposure assessment models in small well-
characterized populations.  SNPs are the commonest and simplest form of human genetic 
variations, and new dense genotyping and sequencing methods along the allelic frequency of 
SNPs makes it possible to identify SNPs highly associated with quantitative biological 
phenotypes.  The SNP association study, exposure modeling, and biological pathway analysis 
conducted in this study is an attempt to provide critical information for development and 
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execution of investigations on the impact of individual genetic variations on the intermediate 
phenotypes.  This research aims to call attention to the individual genetic variations that 
should not be ignored in exposure and risk assessment, as well as disease etiology. 
1.8 Study population and exposure assessment 
1.8.1 Study population 
The study population consisted of 124 U.S. Air Force fuel-cell maintenance workers 
stationed on six U.S. Air Force bases (Chao et al. 2005).  The institute review boards of all of 
the participating research institutions approved the study and the fuel-cell maintenance 
workers were recruited with informed consent into the study.  These workers worked with 
and were exposed to JP-8 to various degrees while performing their military duties.  
Demographic, job tasks, the use of PPE, and work environment related information was 
collected using questionnaires.  Work diaries detailing work tasks and duration were also 
recorded.  The workers were assigned into three exposure groups, high, medium, and low, 
based on the job task on the sampling day.  Anyone who entered a fuel tank was classified 
into high-exposure group, regardless of any other additional jobs performed.  Anyone who 
assisted the entrants (attendant and/or runner) but did not enter the tank was grouped into 
medium-exposure.  The low-exposure group consisted of other field workers who had only 
occasional contact with JP-8.  The average age of the subjects was 24.6 ± 4.98 years.  Of all 
subjects, 116 were males (93.5%), 107 were Caucasians (86.3%), and 53 were smokers 
(42.7%) (Chao et al. 2005). 
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1.8.2 Exposure and biomarker measurements 
In order to measure the exposure of JP-8, naphthalene was chosen as a marker for 
exposure.  We collected skin tape-strip samples (dermal exposure and skin-keratin adduct 
monitoring), breathing-zone and breath samples (inhalation exposure), urine samples (urinary 
metabolites), and blood samples (for SNP genotyping) for this particular study. 
For each worker, three body regions with potential greatest JP-8 exposure were 
selected for dermal sampling after work shift (Chao et al. 2005).  Three sequential tape-strips 
at each region were collected.  Naphthalene was extracted from the tape by acetone and 
analyzed by gas chromatography-mass spectrometry (GC-MS).  Dermal exposure was 
adjusted for the surface area of the particular region sampled in order to estimate the regional 
dermal exposure to naphthalene.  The whole-body dermal exposure was calculated by 
summing the estimated regional dermal naphthalene concentrations of the three sampled 
regions and by conservatively assuming that no exposure to the other un-sampled regions 
occurred (Chao et al. 2005).  Personal breathing-zone exposure was monitored during the 4-h 
work shift with passive monitors attached to the worker‘s shirt collar (Egeghy et al. 2003).  
The level of naphthalene in the breathing-zone air was analyzed by thermal desorption 
followed by GC-MS with photo ionization detection.  Naphthalene and 1- and 2-naphthol 
concentrations were determined from urine samples collected before and after work shift.  
Urinary 1- and 2-naphthol were hydrolyzed, extracted, derivatized, and analyzed by GC-MS 
in single-ion monitoring as described by Serdar et al. (Serdar et al. 2003b).  Total urinary 
naphthol level was calculated by summing the levels of 1- and 2-naphthol.  Urinary 
naphthalene was also measured via headspace solid-phase microextraction followed by GC-
MS analysis as described elsewhere (Serdar et al. 2003a).  The skin naphthyl-keratin adduct 
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samples were collected in the same way as the dermal tape-strip samples at one body site – 
volar arm.  Four naphthyl- keratin adducts (1-naphthyl-keratin-1, 2-naphthyl-keratin-1, 1-
naphthyl-keratin-10, and 2-naphthyl-keratin-10) were analyzed by enzyme-linked 
immunosorbent assay (ELISA) (Kang-Sickel et al. 2008; Kang-Sickel et al. 2010).  The level 
of keratin protein collected by each tape-strip sample was measured to normalize the 
naphthyl-keratin adduct levels in the tape sample (Kang-Sickel et al. 2008; Kang-Sickel et al. 
2010).  The total naphthyl-keratin adduct level normalized by the keratin amount collected by 
each tape for each worker was calculated by summing each normalized level of the four 
adducts measured. 
Dermal exposure to naphthalene was significantly different between the job tasks (P 
< 0.0001) and reflected the actual exposure scenarios in this study population (Chao et al. 
2005).  The fuel-tank maintenance personnel who performed fuel-tank entry tasks had higher 
exposure to naphthalene via both dermal and inhalation routes than those who did not enter 
the fuel tanks (Chao et al. 2005).  Post-exposure levels of urinary 1- and 2-naphthols were 
significantly higher than pre-exposure levels (all P < 0.0001).  Results showed that post-
exposure urinary 2-naphthol levels were greater than post-exposure urinary 1-naphthol levels 
(P < 0.0001).  The 2-naphthyl-keratin adduct levels were also observed to be significantly 
higher than 1-naphthyl-keratin adduct levels (P < 0.0001). 
1.9 Study objectives and specific aims 
In this study, my goal was to investigate the genetic contribution to variation 
observed in biomarkers of exposure can be determined using multiple linear regression 
modeling that accounts for (1) personal exposure (dermal and inhalation), (2) individual and 
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environmental determinants, and (3) candidate gene association and/or genome-wide 
association scans determined by microarray genotyping of workers exposed to jet fuel JP-8.  
I hypothesized that individual genetic differences (SNPs) significantly contribute to the 
variation observed in the levels of systemic exposure (e.g., urine metabolites, skin keratin 
adducts) to naphthalene, a maker for exposure to JP-8.  To achieve my goal and to test this 
hypothesis, I proposed the following specific aims: 
1. Identify SNPs significantly associated with skin biomarkers (1-naphthyl-keratin, 2-
naphthyl-keratin, and total naphthyl-keratin adducts) and urine biomarkers (1-naphthol, 
2-naphthol, and total naphthols) among workers exposed to JP-8 using candidate-gene 
and genome-wide analyses (Chapter 2 & 3). 
2. Investigate the influence and the relative contribution of the significant SNPs, personal 
exposure (dermal and inhalation) as well as individual (e.g., personal protection 
equipment, smoking status) and environmental (workplace) factors on the skin and urine 
biomarker levels using multiple linear regression models (Chapters 2 & 3). 
3. Investigate the biological relevance of the SNP associated sequences and genes identified 
to significantly contribute to the skin and urine biomarker levels in aim 1 (Chapter 2 & 3). 
The results obtained from this project will increase our knowledge of how individual 
genetic variants affect the systemic exposure to JP-8 and the potential for health effects 
through a genetic functional or regulatory pathway.  Ultimately, the developed methods and 
models in this project will allow us to predict the susceptible population to adverse health 
effect and disease, and develop better protection strategies for JP-8 exposed population. 
  
  
CHAPTER 2.  PAPER I: SINGLE NUCLEOTIDE POLYMORPHISMS 
ASSOCIATED WITH SKIN NAPHTHYL-KERATIN ADDUCT LEVELS IN 
WORKERS EXPOSED TO JET FUEL 
Rong Jiang, John E. French, Vandy I. Stober, Juei-Chuan C. Kang-Sickel, Yi-Chun E. Chao, 
Mary Ann Butler, Fei Zou, and Leena A. Nylander-French (manuscript) 
2.1 Abstract 
We investigated individual differences in single nucleotide polymorphisms (SNPs) as 
genetic markers associated with naphthyl-keratin adduct (NKA) levels measured in the skin 
of workers exposed to jet fuel.  The SNP association analysis was conducted in PLINK using 
candidate-gene (CGA) and genome-wide (GWA) analyses.  In CGA, one SNP associated 
gene CYP26B1 was identified to contribute to 2-naphthyl-keratin adduct (2NKA) level based 
on corrected P-value.  In GWA, no single SNP reached genome-wide significance for NKA 
levels (P ≥ 1.05  10-5).  We further provide evidence on the relative contributions of the 
observed SNP markers and the impact of personal and workplace factors on the measured 
biomarker levels using multiple linear regression model and Pratt Index.  In CGA, the model, 
which included SNP related to CYP26B1 and five other covariates, explained about 45% of 
the total variation in the 2NKA level.  Within the context of the models in GWA, the relative 
contribution of the significant SNPs to NKA levels were greater than the five other covariates.  
Pathway and network analyses indicated genes involved in the regulation of cellular and 
homeostasis processes contribute to the level of skin NKA in GWA.  We report here a 
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method and strategy to investigate the role of individual genetic variation in the quantitative 
assessment of biomarker levels in a small well-characterized exposed worker population.  
These tools have the potential to provide biological plausibility to explain the relevance of 
the impact on the biomarker level, mechanistic insight into the etiology of exposure related 
disease, and to identify susceptible subpopulation with respect to exposure. 
2.2 Introduction 
Significant individual variation exists in the systemic response to xenobiotic exposure 
that may be due to individual differences in xenobiotic toxicokinetics, DNA-damage repair 
genes, host factors, other environmentally responsive groups of genes and pathways, etc. 
(Christiani et al. 2008).  The source of variation may be dependent upon single nucleotide 
polymorphisms (SNPs) (Hinds et al. 2006; McCarroll et al. 2008), copy number variations 
(Conrad et al. 2010), and hyper- or hypomethylation patterns in the highly conserved coding 
region of genes or in their regulatory control sequences that may influence protein expression 
and post-transcriptional modifications (Boks et al. 2009; Gibbs et al. 2010),  which may 
affect function critical to xenobiotic metabolism and toxicokinetics and individual 
differences in the maintenance of homeostasis (Adeyemo et al. 2009; Baranzini et al. 2009; 
de Geus et al. 2005; Ehret 2010; Glinskii et al. 2009).  Individual genetic differences may 
lead to differences in toxicokinetics, including activation/detoxification capacity that result in 
different levels of metabolites, tissue distribution and elimination, as well as heritable 
differences in physiological function (blood pressure, heart rate, respiratory rate, etc.).  These 
genetic differences may directly or indirectly contribute to the associated health effects 
(resistance or susceptibility to toxicity and disease).  However, our knowledge of individual 
differences in toxicokinetics and systemic response to xenobiotic exposures, genetic 
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mechanism of toxicity and associated health effects, and the potential value of including 
information on individual genetic variations in exposure assessment models is limited. 
Association analysis can be used to identify SNPs that are significantly associated 
with biological phenotypes, including a specific disease in case-control epidemiology studies 
(Abecasis et al. 2005; Collins 2009; Cordell and Clayton 2005; Suh and Vijg 2005; 
Zondervan and Cardon 2007).  In order to discover genetic variants that may give rise to a 
variation in a phenotype under investigation, an association study can be performed to 
examine phenotype variation against a genotypic variation in a large population.  Current 
association studies are focused on genetic variation and disease endpoints, i.e., either an 
effect is observed or not. Recent studies have shown that mapping intermediate steps in 
disease processes, i.e., intermediate phenotypes (such as various disease-related clinical traits 
or expression levels of genes of interest) rather than merely the binary case-control disease 
status (Chen et al. 2008; Emilsson et al. 2008; Keller et al. 2008; Kim et al. 2001; Lee et al. 
2006) is more informative.  These intermediate traits provide insight into the relationship 
between genetic variation and disease phenotype because they are more directly influenced 
by the genetic variation.  Exposure misclassification in case-control status exists widely in 
epidemiology studies, which directly brings biases to the results.  Meanwhile, the use of 
binary outcome decreases the resolution of the association substantially because the large 
variability in outcome is not captured using dichotomous case-control variables, especially in 
an exposure assessment study.  Quantitative traits are more objective than a categorical 
disease outcome in a case-control study, and can increase the statistical power four to eight 
fold and, therefore, greatly decrease the required sample size to obtain sufficient statistical 
power (Potkin et al. 2009a; Potkin et al. 2009b).  The systemic exposure levels (parent 
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compound or metabolite levels of xenobiotics) may be used as intermediate quantitative traits 
when investigating association between dose-response relationship and individual 
susceptibility to toxicity and disease to improve the resolution compared to using only binary 
disease outcomes. 
Current studies have shown that the interactions between genetic and environmental 
factors are critical to toxicity and disease risk (Christiani et al. 2008; Vineis et al. 2009; 
Vlaanderen et al. 2010).  Therefore, research in this area should include investigation of the 
genetic basis of individual differences in biomarkers of exposure and susceptibility to the 
exposure of various environmental hazards.  Thus, it is imperative that the sources of 
individual genetic variations are accounted for in future epidemiology and exposure 
assessment studies that utilize biomarkers of exposure and/or effect in order to reveal the 
exposure-disease relationships.  Studies, which include individual genetic markers, e.g., 
SNPs as variance components, have the potential to provide mechanistic insight into toxicity 
and the etiology of disease.  Inclusion of the individual genetic variations in exposure 
assessment models may further allow us to identify potential susceptible subpopulations with 
respect to workplace exposure, and provide useful input in setting exposure limits by taking 
into account individual variation that alter exposure classification and, thus, affects 
determination of susceptibility to adverse health effects in the occupational environment. 
Here, we provide an approach and statistical tools to investigate the potential role of 
individual genetic variations in assessment of biomarker levels as an intermediate phenotype 
in a small well-characterized worker population exposed to naphthalene in a complex 
mixture (jet fuel).  Towards this goal, we have demonstrated that the fuel-cell maintenance 
personnel who performed fuel-tank entry tasks had higher exposure to naphthalene (used as a 
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marker of jet fuel exposure) via both dermal (Chao et al. 2005) and inhalation routes (Egeghy 
et al. 2003; Serdar et al. 2004) than those who did not enter the fuel tanks.  We have also 
demonstrated that skin naphthyl-keratin adducts (NKAs) can be used as biomarkers for 
naphthalene-containing jet fuel exposure (Kang-Sickel et al. 2008; Kang-Sickel et al. 2010).  
The goal of this study was to investigate the relative contribution of individual differences in 
SNPs as genetic markers associated with measured biomarker levels (i.e., NKAs) in workers 
exposed to jet fuel along with other personal and workplace factors.  The biological 
relevance of relatively significant SNP associated genes was also investigated using pathway 
and network analysis to better understand the impact of individual genetic variations on the 
observed biomarker level. 
2.3 Methods 
2.3.1 Study Population 
Exposure data was available from the broad exposure assessment and health effects 
study of the U.S. Air Force (USAF) personnel exposed to jet propulsion fuel 8 (JP-8) at six 
USAF bases in the continental United States (Chao et al. 2005; Chao et al. 2006; Egeghy et 
al. 2003).  Workers were recruited with informed consent from active duty personnel who 
routinely worked with or were exposed to JP-8.  While 339 workers were enrolled in the 
overall project, a total of 105 fuel-cell maintenance workers who were monitored for dermal 
exposure were included in this study.  Approval for human subject use was obtained from the 
institutional review board for the USAF and for each of the participating investigators, and 
the study complied with all applicable U.S. requirements and regulations. 
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Questionnaires were collected after work shift to obtain the information on 
demographic factors, including job tasks, the use of personal protective equipment, smoking 
status, and other work related characteristics.  Work diaries for each worker were also 
recorded during the survey, including detailed information on work tasks and task durations.  
Workers in this study included those who entered the plane‘s fuel cell and performed 
maintenance tasks including tank door, bolt, and/or foam removal, foam replacement, fuel 
tank cleaning, depuddling, repairs and inspections (referred to as entrants).  Also included 
were attendants and runners who worked outside the fuel tank to assist entrants (e.g., foam 
removal) and other field workers who performed maintenance with occasional contact with 
JP-8. 
2.3.2 Measurements of Dermal Exposure 
In order to measure fuel-cell maintenance workers‘ exposure to JP-8, naphthalene 
was chosen as a marker for exposure (Chao et al. 2005; Chao et al. 2006).  Measurements of 
dermal exposure have been described previously (Chao et al. 2005).  Briefly, dermal 
exposure to naphthalene was monitored using adhesive tape strips (2.5 cm  4.0 cm, surface 
area 10 cm
2
, Cover-Roll
TM
, Beiersdorf AG, Germany) from exposed body regions of each 
worker after the work shift.  For each worker, three body regions with potential greatest JP-8 
exposure were selected for dermal sampling after work shift (Chao et al. 2005).  Three 
sequential tape-strips at each region were collected and the samples were analyzed by gas 
chromatography-mass spectrometry.  Dermal exposure level was adjusted for the surface area 
of the particular region sampled in order to estimate the regional dermal exposure to 
naphthalene.  The whole-body dermal exposure was calculated by summing the estimated 
regional dermal naphthalene concentrations of the three sampled regions and by 
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conservatively assuming that no exposure to the other un-sampled regions occurred (Chao et 
al. 2005). 
2.3.3 Skin Naphthyl-keratin Adduct Sampling and Analysis 
Dermal tape-strip samples were collected from each worker in the same manner as for 
naphthalene exposure after the work shift [as described previously in Chao et al. (2005) and 
Kang-Sickel et al. (2008; 2010)].  Briefly, for each worker, dermal samples were collected 
from 3 – 5 exposed body regions and three sequential tapes were collected from each site.  
Four naphthyl-keratin adducts (NKA) were quantitated in the tape-strip samples [1-naphthyl-
keratin-1 (1NK1), 2-naphthyl-keratin-1 (2NK1), 1-naphthyl-keratin-10 (1NK10), and 2-
naphthyl-keratin-10 (2NK10)] using enzyme-linked immunosorbent assay (Kang-Sickel et al. 
2008; Kang-Sickel et al. 2010).  The amount of keratin collected in each tape sample was 
determined to adjust the adduct level with the amount of keratin recovered from each tape-
strip sample.  The total 1NK- and 2NK-adduct levels were calculated by summing up the 
keratin-normalized 1NK1- and 1NK10-adduct levels and 2NK1- and 2NK10-adduct levels, 
respectively.  The total naphthyl-keratin adduct (TNKA) level for each worker was 
calculated by summing the four keratin-normalized adduct levels. 
2.3.4 Genotyping and Calling 
Blood (10 ml) was collected into EDTA vacutainer tube from each worker at end of 
the work shift.  Blood samples were shipped overnight to the laboratory on Blue Ice

 
(Rubbermaid, Atlanta, GA) to maintain a temperature of 4C, aliquoted into 1.8 ml cryovials, 
and stored in –70°C until analysis.  DNA was isolated using Puregene DNA extraction kit 
(Gentra, Minneapolis, MN) from 0.5 ml of whole blood.  DNA was quantified using a 
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NanoDrop (Thermo Fisher Scientific).  Concentration of DNA and cleanup (desalting) for 
increased purity was carried out by vacuum centrifuge (Savant Instruments Inc., Holbrook, 
NY) or ethanol precipitation, respectively.  Once the DNA was obtained at a concentration 
greater than 50 ng/µl with a purity of 1.8 or higher, a gel was run to verify that DNA was 
intact.  DNA was processed as per the Affymetrix protocol for analysis using the GeneChip
®
 
Human Mapping 250k StyI SNP array set (Affymetrix, Santa Clara, CA) using a StyI 
digestion.  In brief, 250 ng of DNA was digested using StyI restriction enzyme.  An adaptor 
was ligated to the digested fragments and PCR performed using the added adapter sequences 
as primers.  PCR products were cleaned and normalized prior to fragmentation and labeling 
with the fluorochrome.  Arrays and samples were submitted to the UNC-CH Affymetrix Core 
for hybridization, washing, and reading of the array using the Affymetrix platform equipment 
to obtain individual SNP data. 
Array images were acquired by scanning each array and raw DAT-image files were 
generated in GeneChip
®
 Operating System (GCOS) software at UNC-CH Affymetrix Core.  
Each raw DAT image was processed by GCOS into CEL file, which was later run in 
Affymetrix Genotyping Console 3.0.1 using BRLMM algorithm to genotype ~238,000 SNPs 
for each worker.  Each SNP genotype was generated as AA, AB, BB, or ―no call‖ if the 
confidence value was less than 0.5. 
2.3.5 Data Cleaning 
Among 105 workers, 3 workers were excluded due to low genotype rate (missing 
genotype rate per person >10%).  In addition, 28,445 markers with low genotype rate 
(missing genotype per SNP >10%), 18,744 SNPs with less than 1% minor allele frequency 
(MAF <0.01), and 4,840 SNPs with Hardy-Weinberg departure (P < 0.001) were excluded 
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from the association test.  The SNPs on X chromosome were excluded for simplification.  
After data cleaning, we obtained a set of 102 exposed workers with 184,153 SNPs for 
association tests with skin NKA levels.  The average call rate was 98.1%. 
2.3.6 Statistical Analyses 
The descriptive statistics of the dermal exposure and the total skin NKA levels 
(1NKA, 2NKA, and TNKA) and comparison between total 1NKA and total 2NKA levels 
were performed using SAS 9.2 (SAS Institute, Cary, NC).  Association analysis between 
SNP alleles and total 1NKA, 2NKA, and TNKA levels was performed using PLINK version 
1.06.  All skin NKA levels and the measured naphthalene dermal exposure levels were log-
transformed to meet the normal distribution assumption.  Additive effect was used for SNP 
allele dosage and coded as 0 = AA, 1 = AB, 2 = BB; in this way, the mean value of 
biomarker level increases with the variant allele frequency.  SNP associations were 
investigated using candidate-gene and genome-wide approaches controlling for other 
important covariates.  SNPs associated with each corresponding adduct level were selected as 
potential independent variables in the exposure assessment model containing other 
significant personal and workplace covariates in order to investigate the relative contribution 
of individual genetic variation to these adduct levels. 
SNP association analysis was performed by controlling for personal and workplace 
factors that were observed to significantly contribute to the measured levels of skin NKAs.  
To accomplish this, multiple linear regression models (MLRMs) were developed using SAS, 
which included dermal naphthalene level and the significant personal and workplace factors 
( = 0.1).  The general form of a linear regression model is given as follows: 
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
Yi  0   p X ip qCiq i
q1
Q

p1
P
  (1) 
where Yi represents the natural logarithm of the NKA level of the i
th
 worker, Xip represents 
the p
th
 natural logarithm of the dermal naphthalene level for the i
th
 worker, Ciq represents the 
q
th
 covariate value for the i
th
 worker (i.e., personal and workplace factors), βp and γq represent 
the regression coefficient for p
th
 dermal naphthalene level, and q
th
 covariate, respectively, β0 
is the intercept, and εi is the random error for the i
th
 worker. 
The STEPWISE model selection was used in PROC REG to determine regression 
model 1 using dermal naphthalene level and other covariates as potential independent 
variables.  Only naphthalene through dermal route of exposure can induce formation of 
NKAs in the skin (i.e., these adducts are route specific indicators of exposure; inhalation 
exposure will not contribute to the formation of these adducts).  Possible collinearity 
problems were investigated using eigenvalue analyses and variance inflation factors.  
Possible outliers were examined using studentized residuals.  Residual analysis was 
performed to check if the fitted models meet all assumptions. 
SNP association analysis was performed controlling for the covariates determined in 
the previous step (model 1).  PLINK allows for multiple covariates when testing for 
quantitative trait using linear models.  The general form of the linear model in PLINK is 
given as follows: 
 

Yi  0  gSi g   pX i p   qCi q  i
q1
Q
  (2) 
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where Sig represented the g
th
 tested SNP type for the i
th
 worker as individual genetic data; and 
λg represented the coefficient for g
th
 SNP.  Everything else remained the same as in model 1.  
One SNP association was tested at a time controlling for covariates using model 2. 
First, we focused the analysis using SNPs as genetic markers to identify associations 
with candidate genes.  The selection of candidate genes was based on their known or 
expected functional and/or regulatory roles in the metabolism and toxicokinetics of 
naphthalene and or similar chemicals [i.e., polyaromatic hydrocarbons (PAHs)] as 
indicated in the peer-reviewed published literature.  The expression of various genes related 
to antioxidant responses and detoxification, including those for glutathione-S-transferases 
(GSTs) and cytochrome P450 (CYP) proteins, were upregulated after exposure to JP-8 
(Espinoza et al. 2005; Kang-Sickel et al. 2010).  The functional status of these enzymes and 
their relative contribution to the metabolites may be critical to the understanding of 
individual variations in responses to JP-8 exposure.  In addition to these metabolic enzymes, 
other altered gene expressions in regulatory regions have been reported after exposure of JP-
8.  For example, genes involved in basal transcription and translations were upregulated in 
human epidermal keratinocytes, whereas genes related to DNA repair were mostly 
downregulated (Chou et al. 2006).  Genes coded for growth factors, apoptosis, signal 
transduction, and adhesion were also altered (Chou et al. 2006).  SNPs on candidate genes 
were obtained using Affymetrix NetAffy Analysis Center search results 
(www.affymetrix.com/analysis/index.affy), which provides all SNPs physically related to 
each candidate gene using 250K StyI array.  Table 2.1 shows the list of 35 candidate genes 
and the number of SNPs related to that gene tested for association with skin NKA levels.  
Since some SNPs were shared by more than one candidate gene, and some SNPs were 
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excluded by data cleaning procedure, 498 SNPs on the candidate genes selected were 
retained for candidate-gene analysis (CGA). 
After CGA, we performed genome-wide analysis (GWA) to probe for unknown SNPs 
that may not be a candidate gene for naphthalene toxicokinetics.  GWA was used to identify 
any SNPs significantly associated with 1NKA, 2NKA, and/or TNKA levels regardless of 
mechanism.  Empirical P-values were calculated using max(T) permutation approach 
implemented in PLINK for both CGA (N = 10,000 permutations) and GWA (N = 10,000 
permutations) as well as by Bonferroni correction.  The benefit is that the P-values were now 
adjusted for all SNPs tested using the 250K StyI array.  Because the permutation schemes 
preserve the correlation structure between SNPs, this provides a less stringent correction for 
multiple testing in comparison to the Bonferroni correction, which assumes that all tests are 
independent.  The overall level of significance used was 0.1.  Genome-wide plots were 
generated in R using package ―gap‖ (Zhao 2007) for SNPs associated with each skin NKA 
level.  The goal of the association test was to identify SNPs that are most significantly 
associated with skin NKA levels in order to construct the final exposure model that 
incorporates these SNPs. 
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Table 2.1 Candidate genes (N = 35) and the number of SNPs (n = 498) tested for 
association with skin naphthyl-keratin adduct levels in fuel-cell maintenance 
workers using candidate-gene analysis. 
Gene 
Number of 
SNPs 
 Gene 
Number of 
SNPs 
 Gene 
Number of 
SNPs 
AHR 67  CYP2A6 4  EPHX1 4 
AKR1C1 19  CYP2B6 4  EPHX2 19 
AKR1C2 22  CYP2C18 1  GSTM3 2 
AKR1C3 22  CYP2C19 9  GSTM5 2 
AKR1C4 29  CYP2C8 10  GSTT1 1 
ARNT 2  CYP2C9 9  GSTT2 6 
ARNT2 47  CYP2D6 0  NQO1 1 
CRABP1 8  CYP2E1 13  SOD1 7 
CYP1A1 3  CYP3A4 1  SOD2 64 
CYP1A2 29  CYP3A5 2  SOD3 18 
CYP1B1 38  CYP3A7 3  SRD5A2 11 
CYP26B1 51  CYP4B1 10    
Note: The total number of SNPs is 537 in this table, because some SNPs are shared by more than one 
gene, only 498 independent SNPs were tested on 35 genes. 
 
To investigate the proportion of explained variance in individual biomarker levels 
(i.e., NKA levels), we examined the relative contribution of individual SNP markers 
potentially involved in naphthalene metabolism and toxicokinetics and the contribution of 
personal (e.g., personal protection, smoking) and workplace (e.g., job, task, work 
environment) factors due to dermal exposure to jet fuel.  The MLRMs were developed using 
SAS and the significance was evaluated at -level of 0.1.  Once significant SNPs associated 
with skin NKA levels were identified from CGA and GWA, these SNP types were selected 
as potential independent variables for construction of the final model and computation of the 
relative contribution of these SNPs to the NKA levels along with the significant personal and 
workplace factors.  The general form of MLRM was modified to: 
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
Yi  0   p X ip qCiq  gSig i
g1
G

q1
Q

p1
P
  (3) 
More than one SNP and significant covariates were selected as potential independent 
variables.  STEPWISE selection was used in PROC REG to determine regression model 3 
and model analysis was performed using the same methods as in model 1. 
The relative contribution of each predictor in the final regression models were 
determined by the proportionate contribution that each predictor made to the regression 
model R
2
 using Pratt index, which is the product of its estimated standardized regression 
coefficient and the simple correlation between that predictor and the outcome variable (Chao 
et al. 2008; Pratt 1987).  The relative contribution considered in this investigation is the 
dispersion importance, i.e., the proportion of the variance in outcome variable accounted for 
each predictor in the regression model. 
2.3.7 Bioinformatic Analysis of Highly Associated SNPs and Network Interactions 
All SNPs identified by statistical significance and the relative contribution to the 
observed variance in the NKA levels were investigated and the curated sequence 
identification, location, and gene ontology established using NCBI Entrez Gene 
(http://www.ncbi.nlm.nih.gov/snp), Ensembl BioMart (http://www.biomart.org), and/or 
UCSC gene browser (http://genome.ucsc.edu).  The potential for SNP associated candidate 
gene interactions affecting the biomarker levels was identified in the GWA strategy 
described above and tested for statistical significance by MetaCore integrated knowledge 
database and software suite for pathway analysis (GeneGo.com) using their proprietary 
database of hand-curated peer-reviewed literature and statistical analysis of network 
interactions (Brennan et al. 2009; Chang 2009).  Highly relevant candidate gene functions 
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were corroborated by further literature analysis of the predicted associations (formula 
available from MetaCore, GeneGo.com by request).  Transcriptional factor binding sites 
(KLF6 and CREB1) on core promoter sequences of keratin 1 (KRT1) and keratin 10 (KRT10) 
target genes not identified in the peer-reviewed literature were predicted by Genomatix 
TransFac MatInspector (Cartharius et al. 2005) to confirm KLF6 and CREB1 transcription 
factor binding sites in the promoter region of epithelial KRT1 and KRT10.  Briefly, the 
KLF6 and CREB1 transcription factor binding site sequence identified on keratin 12 (KRT12) 
(Chiambaretta et al. 2002; Wang et al. 2002) was used to weight and develop a training set to 
interrogate similarity matrices and to identify predicted binding sites.  Ultimately, the 
significance of the candidate variant genes must be functionally established by further 
genetic and molecular analysis. 
2.4 Results 
2.4.1 Study Population and Exposure Measurements 
After data cleaning, there were 184,153 SNPs and 102 workers available for 
association analyses.  The workers included 94 males (92.2%) and 8 females (7.8%) of 
whom 89 were Caucasians (87.3%), 13 were non-Caucasians (African-American, Hispanic, 
or Asian; 12.7%), and 45 were smokers (44.1%).  The average age of the workers was 24.6 ± 
5.0 years and ranged from18 – 40 years. 
The geometric mean (GM) and geometric standard deviation (GSD) of dermal 
naphthalene level were 1556 and 8.6 ng/m
2
 with a range of 100 ng/m
2
 – 5090 µg/m2.  The 
total 1NKA and 2NKA were detected in the tape-strip samples at levels from 0.27 to 6.4 
pmole adduct/µg keratin.  The GM ± GSD for 1NKA, 2NKA, and TNKA levels were 0.7 ± 
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1.5, 2.1 ± 1.5, and 2.8 ± 1.5 pmole adduct/µg keratin, respectively.  The GM for 1NKA level 
was significantly different (P < 0.0001) from that of 2NKA level.  Covariates for dermal 
exposure, exposure time, age, ethnicity, and the task replacing foam, were significantly 
associated with 2NKA and TNKA levels (Table 2.2, all P < 0.094).  However, smoking, but 
not ethnicity, was significantly associated with 1NKA level (Table 2.2, P < 0.086).  CGA 
and GWA for significant SNPs were performed for 2NKA and TNKA levels by controlling 
for the significant covariates age, exposure time, dermal exposure, ethnicity, and the task 
replacing foam.  In association analyses for 1NKA level, ethnicity was replaced with 
smoking status.  Due to missing exposure time information for 2 subjects, 100 subjects were 
included in the CGA and GWA models. 
Table 2.2 Regression analyses of the significant covariates for the skin naphthyl-keratin 
adduct levels [ln(ng adduct/µg keratin)] in the U.S. Air Force personnel (n = 
100) exposed to jet fuel. 
Adduct R
2
 Predictor Parameter Estimate Standard Error P-value 
1NK 0.271 Intercept -0.416 0.285 0.147 
  Dermal exposure -0.033 0.019 0.083 
  Age -0.018 0.008 0.020 
  Exposure time 0.002 0.001 0.013 
  Replace foam 0.325 0.087 0.0003 
  Smoking 0.132 0.076 0.086 
2NK 0.353 Intercept 0.633 0.239 0.010 
  Dermal exposure -0.052 0.016 0.001 
  Age -0.017 0.006 0.008 
  Exposure time 0.004 0.001 <0.0001 
  Replace foam 0.147 0.072 0.043 
  Ethnicity -0.173 0.094 0.068 
TNK 0.354 Intercept 0.941 0.234 0.0001 
  Dermal exposure -0.047 0.015 0.003 
  Age -0.017 0.006 0.007 
  Exposure time 0.004 0.001 <0.0001 
  Replace foam 0.186 0.070 0.009 
  Ethnicity -0.155 0.092 0.094 
1NK = 1-naphthyl-keratin; 2NK = 2-naphthyl-keartin; TNK = total naphthyl-keratin. 
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2.4.2 Candidate-gene Analysis 
Based on the corrected P-values at -level 0.1, one SNP (rs4852279, MAF = 0.451) 
related to CYP26B1 was significantly associated with 2NKA level (adjusted permutation P = 
0.0449, Bonferroni P = 0.0515).  No SNPs were observed to be significantly associated with 
1NKA or TNKA level.  This model, which included SNP rs4852279 (related to CYP26B1) 
and other five covariates significantly affecting 2NKA level, explained about 45% of the 
total variation in the observed 2NKA level (R
2
 = 0.450).  As described by this model, the 
relative contribution of this SNP was 19%, which was greater than the individual 
contributions of dermal exposure itself, the task replacing foam, age, or ethnicity alone. 
2.4.3 Genome-wide Analysis 
The results for SNP associations with each skin NKA level are presented in the 
genome-wide plots in Figure 2.1.  No single SNP reached genome-wide significance (i.e., 5  
10
-7
 – 1  10-8) (Chung et al. 2010).  The associations between the most significant SNPs for 
1NKA, 2NKA, and TNKA levels were at P = 1.20  10-5 (rs2286321), P = 1.05  10-5 
(rs11889897), and P = 1.75  10-5 (rs4971689), respectively.  The locations and the patterns 
of significant SNPs associated with the skin NKA levels varied for each adduct type. 
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Figure 2.1 Manhattan plots for the associations between the –log10P values of the skin 
naphthyl-keratin adduct levels controlled for covariates for 184153 SNPs and 
the SNP physical chromosome location. 
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We selected the 10 SNPs with the lowest unadjusted P-values along with 
corresponding significant covariates to investigate their effects and relative contributions to 
each NKA level using MLRM.  In addition to dermal exposure, exposure time, age, and the 
task replacing foam, the models for 2NKA and TNKA levels also included ethnicity as a 
covariate.  The model for 1NKA level included the same covariates except that smoking 
status replaced ethnicity.  In the final models, 6, 5, and 5 SNPs were retained as significant 
for 1NKA, 2NKA, and TNKA levels, respectively (Table 2.3).  These final models explained 
66%, 72%, and 73% of the total variation in the 1NKA, 2NKA, and TNKA levels, 
respectively.  Within the context of these models, the relative contribution of these SNPs to 
1NKA, 2NKA, and TNKA levels reached 64%, 55%, and 45%, respectively. 
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Table 2.3 Regression models for skin naphthyl-keratin adduct levels measured in the fuel-
cell maintenance workers using genome-wide analysis. 
Adduct n R
2
 Predictor 
Parameter  
Estimate 
Standard  
Error 
P-value 
Relative 
 Contribution (%) 
1NK 90 0.665 Intercept -0.821 0.297 0.007  
   Exposure time 0.002 0.001 0.014 6.71 
   Dermal exposure -0.029 0.014 0.037 0.34 
   Replace foam 0.325 0.068 <0.0001 22.49 
   Age -0.016 0.006 0.009 3.56 
   Smoking 0.156 0.059 0.010 2.58 
   rs33977056 0.141 0.047 0.003 13.36 
   rs2000753 -0.177 0.056 0.002 11.63 
   rs3799570 0.161 0.058 0.007 10.49 
   rs1329508 0.103 0.048 0.035 10.10 
   rs2286321 0.127 0.052 0.016 9.71 
   rs10413028 0.145 0.057 0.013 9.02 
2NK 87 0.721 Intercept 0.783 0.239 0.002  
   Exposure time 0.004 0.001 <0.0001 28.65 
   Dermal exposure -0.061 0.013 <0.0001 3.90 
   Replace foam 0.105 0.060 0.084 4.90 
   Age -0.016 0.005 0.003 4.66 
   Ethnicity -0.156 0.069 0.026 2.74 
   rs11251918 0.196 0.047 <0.0001 14.10 
   rs9835822 -0.135 0.040 0.001 13.97 
   rs6486693 -0.107 0.038 0.007 11.40 
   rs4971689 0.159 0.043 0.0004 11.37 
   rs9295589 -0.098 0.047 0.039 4.30 
TNK 83 0.729 Intercept 0.831 0.238 0.001  
   Exposure time 0.005 0.001 <0.0001 39.65 
   Dermal exposure -0.066 0.012 <0.0001 2.13 
   Replace foam 0.100 0.055 0.075 4.87 
   Age -0.021 0.005 <0.0001 5.52 
   Ethnicity -0.192 0.064 0.004 2.59 
   rs1962392 -0.135 0.036 0.0004 12.03 
   rs11251918 0.171 0.044 0.0002 11.50 
   rs4971689 0.145 0.040 0.001 10.43 
   rs3799570 0.128 0.043 0.004 6.17 
   rs9295589 -0.122 0.042 0.004 5.11 
1NK = 1-naphthyl-keratin; 2NK = 2-naphthyl-keartin; TNK = total naphthyl-keratin; n = number of 
workers. 
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2.4.4 Bioinformatics 
Eleven SNPs (Table 2.4) were identified by GWA and MLRM analyses and 
associated with skin NKA levels measured in the fuel-cell maintenance workers.  Eight of 
these highly associated SNPs were within or proximate to their most likely associated cis-
related genes (ADD3, CD47, RPS6KA2, KLF6, PARK2, MSRA, NRSN1, and NRXN1) that 
possibly interact through 3 networks predicted (Figure 2.2) by observed interactions as 
presented in the curated literature (Metacore, GeneGo.com). 
 
Table 2.4 SNP variants and genes associated with the naphthyl-keratin adduct levels and 
the other significant covariates affecting naphthalene exposure in the fuel-cell 
maintenance workers as identified by genome-wide analysis and multiple linear 
regression models. 
Chr 
Build 37.1 
Position 
SNP Alleles Associated Genes MAF 
GWA 
P-value 
2p14 63597786 rs33977056 A/G C2orf86 0.208 2.24E-05 
2p16.3 50775436 rs4971689 C/G NRXN1 0.292 2.76E-05 
2q37 241653539 rs2286321 A/G SNED1 0.222 4.19E-05 
3p13.1 109214614 rs9835822 C/T BBX;CD47 0.293 1.83E-05 
6p22 23553309 rs9295589 A/G RPL6P18;NRSN1 0.223 6.88E-05 
6q26 162672040 rs2000753 C/T PARK2 0.266 2.79E-05 
6q27 166950610 rs3799570 C/T RPS6KA2 0.162 3.23E-05 
8p23.1 10299783 rs1962392 C/G MSRA 0.302 5.80E-05 
10p15 3535288 rs11251918 G/T PITRM1;KLF6 0.138 5.29E-05 
10q25.1 110184413 rs1329508 A/G SORCS;ADD3 0.358 7.26E-05 
12q24.32 127551455 rs6486693 C/T TMEM132C 0.470 9.03E-05 
MAF = minor allele frequency; GWA = genome-wide analysis 
 
  
 
Pathway Network Gene Ontology Processes P-Value zScore 
A CD47, RPS6KA2, 
KRT12, KLF6, 
MSRA 
Positive regulation of cellular process (69.6%; 6.52E-17), positive 
regulation of biological process (71.7%; 9.40E-17), chemical homeostasis 
(39.1%; 5.92E-13), regulation of biological quality (54.3%; 6.59E-12), 
homeostatic process (41.3%; 1.09E-11) 
3.01E-19 83.29 
B APOA1, CAV1, 
CD47, ADD3, 
MSRA 
Regulation of biological quality (57.5%; 9.50E-12), homeostatic process 
(42.5%; 7.72E-11), cellular component movement (35.0%; 2.27E-10), 
positive regulation of biological process (60.0%; 4.78E-10), response to 
stimulus (75.0%; 5.59E-10) 
2.09E-15 70.13 
C NRXN1, NRSN1, 
ESR1 (nuclear), 
NLGN1, AHR 
Neuron differentiation (47.1%; 3.37E-08), negative regulation of cell cycle 
(29.4%; 9.14E-08), axon guidance (29.4%; 2.11E-07), synapse assembly 
(23.5%; 2.15E-07), generation of neurons (47.1%; 3.11E-07) 
5.95E-07 55.52 
Figure 2.2 Predicted MetaCore™ network interactions from eleven polymorphic SNP genetic markers associated with the skin 
naphthyl-keratin adduct levels measured in the fuel-cell maintenance workers. 
4
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The first predicted network involves CD47, RPS6KA2, KLF6, and MSRA (Figure 
2.2A), which are associated with the positive regulation of cellular and biological processes, 
chemical homeostasis, regulation of biological quality, and homeostasis (P = 3.01  10-19).  
CD47 is an integrin-associated signal transducer, which is involved in the increase in 
intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix.  
The encoded protein is also a receptor for the C-terminal cell-binding domain of 
thrombospondin, and it may play a role in membrane transport and signal transduction 
(Brown and Frazier 2001; Rebres et al. 2001).  KLF6 and RPS6KA2 appear to interact within 
a predicted network that is strongly associated with the regulation of cell proliferation and 
differentiation, including keratinocytes and, thus, might influence skin NKA levels in the 
workers in this study.  RPS6KA2 is affected by a mitogen-activated protein kinase (MAPK) 
and phosphorylates various substrates, including members of the MAPK signaling pathway.  
This kinase can phosphorylate CREB1, a transcription factor that both up-regulates and 
suppresses many other critical genes in cell proliferation and differentiation.  The KLF6 
transcription factor, a member of the Krueppel-like family, can up-regulate KLF4 (which has 
overlapping functions with KLF6) and, along with the transcription factor CREB1, up-
regulate corneal KRT12 as well as the major keratins of human skin (KRT1 and KRT10) 
(Chiambaretta et al. 2002; Wang et al. 2002).  Bioinformatic analysis indicates that 
consensus transcription binding site sequences in KRT12 for both KLF6 and CREB1 
transcription factor sites are predicted in KRT1 and KRT10 on or near their core promoter 
sequence.  Multiple transcript variants encode different isoforms that have been found for 
this gene, some of which are implicated in carcinogenesis.  KLF6 has also been described as 
a tumor suppressor gene (Miyaki et al. 2006; Narla et al. 2001; Reeves et al. 2004) and has 
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been associated by epidemiologic genome-wide association studies (GWAS) with a number 
of diseases (Liu et al. 2010; Spinola et al. 2007).  MSRA, a cytosolic methionine-S-sulfoxide 
reductase, carries out the enzymatic reduction of methionine sulfoxide to methionine and 
MSRA genes are differentially expressed in human skin (Taungjaruwinai et al. 2009).  This 
enzyme functions are to repair of oxidative damage to proteins and to restore biological 
activity.  RA regulates MSRA expression via two promoters and three transcript variants 
encoding different isoforms have been observed that may alter function or tissue specificity 
(Pascual et al. 2009). 
In the second predicted pathway, ADD3, along with MSRA and CD47, may also 
interact independently with APOA1 and CAV1 (Figure 2.2B) to regulate biological quality, 
homeostasis, cellular components of movement, positive regulation of biological process, 
and response to stimuli (P = 2.09  10-15).  ADD3 is a member of a family of heteromeric 
proteins composed of different subunits referred to as adducin alpha, beta and gamma.  The 
three subunits are encoded by distinct genes and belong to a family of membrane skeletal 
proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of 
cell-cell contact in epithelial tissues (Joshi et al. 1991; Kaiser et al. 1989).  ADD3 has been 
identified in GWAS studies associated with genetic variation and blood pressure and 
hypertension phenotypes (Bianchi et al. 2005; Seidlerova et al. 2009).  CD47, as described 
above, also encodes a membrane protein, which is involved in the increase in intracellular 
calcium concentration that occurs upon cell adhesion to extracellular matrix.  The encoded 
protein is also a receptor for the C-terminal cell-binding domain of thrombospondin, which 
may play a role in membrane transport and signal transduction (Brown and Frazier 2001; 
Rebres et al. 2001).  APOA1 encodes the protein, apolipoprotein A-I, a major protein 
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component of high-density lipoprotein (HDL) in plasma.  This protein promotes cholesterol 
efflux from tissues to the liver and intestine for excretion. Two cysteine disulfide bonds are 
required for ABCA1 transport of APOA1 and are thus potential sites of adduction (Hozoji et 
al. 2009).  CAV1 encodes a scaffolding protein, which is the main component of the caveolae 
plasma membranes found in most cell types.  This protein links integrin subunits to the 
tyrosine kinase FYN, an initiating step in coupling integrins to the RAS-ERK pathway and 
promoting cell cycle progression (Wary et al. 1998). 
In the third pathway, NRXN1 and NRSN1 are associated with neuron differentiation, 
negative regulation of cell cycle, axon guidance, synapse assembly, and generation of 
neurons in the published literature (Figure 2.2C).  NRXN1 and NRSN1 are associated 
NRXN1 (Neurexin 1) interacts with membranes and epidermal growth factor (EGF) through 
cysteine rich 6-laminin G-like domain calcium mediated receptors and 1 calcium binding 
EGF domain, which also may be targets for electrophile adduction that affect ectodermal 
derived tissues.  NRSN1 (Neurensin 1), a vesicular membrane protein, as well as NRXN1 
and NLGN1 may be predicted to interact through the transcriptional factors ZNF217, AHR, 
and ESR1 and the kinases HDAC1 and HDAC2 through ubiquitin and the histone 
deacetylases (HDAC1 and HDAC2).  NRSN1 and NRXN1 are integral to basement 
membranes of the nervous system (Lise and El-Husseini 2006) and may have functions in 
other ectodermal derived tissues not yet described.  Both NRXN1 and NRSN1 expression is 
controlled by REST (RE1-silencing transcription factor, which is also a member of the 
Krueppel-type zinc finger transcriptional factor family like KLF6).  We speculate that 
NRXN1, NRSN1, and NLGN1 have functions other than neuron synapse development or its 
tissue specific restrictions have been relaxed in the skin due to silencing of the tissue specific 
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insulators or they may provide targets for adduction due to their cysteine rich protein 
structure.  In the skin, we can speculate that tissue specific relaxation of expression might 
have an effect on membrane transport and/or epidermal keratinocyte differentiation. 
The other three SNPs in or proximate to genes (SNED1, TMEM132C, and C2orf86,), 
although significant SNP associated genes in the GWA, either has no known relevant 
function to skin or appear to be structural proteins integral to cell or basement membranes.  
Both NRXN1 and SNED1 appear to be independent of any known cellular functions in the 
skin.  However, the proteins might represent targets for adduction due to the number of 
cysteine residue targets.  SNED1 is involved in the regulation of cell-matrix adhesion and 
calcium ion binding (Strausberg et al. 2002).  TMEM132C is a structural transmembrane 
protein, found in undifferentiated neuronal progenitor cells, whose expression is also 
controlled by the REST transcription factor (Rock et al. 2007) and it is thought that it may act 
as a master negative regulator of neurogenesis.  C2orf86 has no known function reported in 
the scientific literature at this time (Katayama et al. 2005) 
2.5 Discussion 
Individual genetic variation that results in potential significant differences in systemic 
response to exposure to xenobiotics are not accounted for as predictors of outcome in current 
exposure assessment models.  New dense genotyping and sequencing methods to determine 
the allelic frequency of SNPs makes it possible to identify SNPs highly associated with 
quantitative biological phenotypes.  The goal of our study was to investigate SNPs as genetic 
markers for genetic loci that modify measured biomarker levels (i.e., skin NKAs) for use in 
exposure assessment models.  The quantitative trait of skin NKA level can be treated as an 
intermediate phenotype in a statistical genotype–phenotype association study, thus, providing 
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an increased power to detect quantitative associations in well-defined exposed populations 
compared to using a binary case-control outcome (i.e., disease) with less well-defined 
covariates. 
Previously, we demonstrated that human skin expresses xenobiotic metabolism 
enzymes and that naphthyl-keratin adducts are formed in response to naphthalene exposure 
that can be quantitatively measured in the exposed skin of workers and used as biomarkers of 
dermal exposure to jet fuel (Kang-Sickel et al. manuscript; Kang-Sickel et al. 2008; Kang-
Sickel et al. 2010).  Further, we examined the effects of four a priori selected metabolic 
genotypes (CYP2E1, GSTM1, GSTT1, and NQO1) on the measured TNKA levels in the skin 
and on the urine biomarker levels using linear regression modeling (Kang-Sickel et al. 
manuscript).  We observed that the TNKA level, post-exposure breath naphthalene level, as 
well as the presence of GSTT1-plus (++/+-) and CYP2E1*6 wild-type (DD at the DraI 
restriction site of intron 6) significantly influenced urine naphthalene levels.  However, we 
also observed that the effect sizes of the personal and environmental factors, such as 
exposure duration and dermal naphthalene level, might outweigh the effect associated with 
these metabolic genotypes.  These results demonstrate the complexity and difficulty to 
investigate the role of individual variability and susceptibility factors along with quantitative 
exposure measurements to understand on the potential health effects of environmental 
hazards. 
In the CGA approach describe here, we identified one SNP genetic marker related to 
CYP26B1 that was significantly associated with the 2NKA level, based on the corrected P-
value.  The relative contribution of this SNP marker in the final model was greater than the 
contribution of dermal exposure, task of replacing foam, age, or ethnicity alone.  The 
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contribution of this SNP genetic marker to skin NKA level may be related to CYP26B1 
function in the control of all-trans-retinoic acid (RA).  CYP26B1 gene encodes an enzyme 
involved in the inactivation of RA to hydroxylated forms, such as 4-oxo-, 4-OH-, and 18-
OH-RA.  RA is a regulator of epidermal proliferation and differentiation.  RA also induces 
keratinocyte proliferation and, thus, epidermal hyperplasia (Giltaire et al. 2009).  RA is the 
only recognized substrate of CYP26B1 detected in human skin, mainly in the epidermal basal 
layer (Ray et al. 1997).  RA has shown to inhibit mRNA and protein expression of KRT10 in 
autocrine high-cell density cultures of epidermal keratinocytes in vitro (Poumay et al. 1999).  
The variations in CYP26B1 expression may result in different levels of RA in the skin 
leading to differences in KRT10 protein through keratin expression and, thus, impact the skin 
NKA levels observed in this study. 
We recognize that our inability to identify more than one significant SNP on 
candidate genes may be indicative of the low-density probes in Affymetrix StyI array used.  
Among 498 SNPs on candidate genes, only 9 were placed within exons (CYP1A2, ARNT2, 
EPHX1, EPHX2, CYP26B1, GSTM3, CYP4B1), and 87 were placed within introns; the others 
were either 5‘ or 3‘ of potential target genes.  Even the SNP (rs4852279) significantly 
associated with 2NKA level is about 90 kb 5‘ from the CYP26B1 gene region.  The sparse 
probe set may leave those SNPs with a greater effect size unidentified and miss the SNPs 
associated with the observed biomarker levels.  Furthermore, the selection of candidate genes 
in this study was limited to genes involved in the metabolism and toxicokinetics of 
naphthalene and PAHs, excluding genes on other biological processes, such as cell 
proliferation and differentiation, cell signaling, regulation of physiological states, etc., which 
may be critical in the level of skin NKA.  To improve the density of SNP probe, high-density 
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SNP probe array such as Affymetrix Genome-wide Human Array 6.0 (genotyping more than 
906,000 SNPs) could be used in future studies.  In addition, imputation could be applied to 
provide a route to testing additional SNPs without further genotyping.  SNPs can be imputed 
with considerable reliability from the HapMap panel (Collins 2009).  Imputation has the 
potential to improve the fine mapping resolution in candidate regions. 
Current genotyping platforms in use select SNP templates for analysis based upon 
their linkage disequilibrium patterns that support the best genome coverage of the base-pair 
positions across the chromosomes rather than coverage of genes in particular pathways or 
networks.  This makes SNP assignments to genes and pathways inherently difficult, but not 
impossible, in a reiterative approach and strategy as described here.  In this context, the SNPs 
that were statistically associated with a phenotype were considered as a polymorphic genetic 
biomarker with no inference for the basis for the SNP-phenotype association.  Thus, genetic, 
epistatic, epigenetic, and or non-coding RNA gene regulation interactions were not excluded 
in establishing the predicted networks that may be associated with individual variation and 
biomarker levels observed along with other predictors of naphthalene exposure.  Although 
the GWA results did not show any significant SNP association with skin NKA levels at a 
level of genome-wide significance, three biologically plausible predicted networks were 
obtained using SNPs identified by PLINK and MLRM as significant predictors and high 
relative contribution in the models tested.  An association test for single SNP has limited 
utility and is insufficient to disclose the complex genetic structure of many diseases or 
biomarker levels among exposed subjects.  Diseases often arise from the joint action of 
multiple loci within a genetic structure or joint action of multiple genes within a pathway 
(Luo et al. 2010).  Although each single SNP may confer only a small disease risk or effect, 
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their joint actions are likely to have a significant risk effects.  The predicted pathway and 
networks show that the identified SNP associated genes are not independent but may interact 
with each other and that they can work collectively through meaningful biological processes 
to contribute to the skin NKA levels in exposed workers.  The significant SNP variants 
identified in this study are highly associated with the regulation of cellular processes and 
homeostasis and may also provide targets for adduction by naphthalene electrophilic 
metabolites.  These identified genetic associations need to be replicated and their biological 
functions must be validated.  Thus, this discovery study has generated new information on 
the potential biological functions of genetic factors affecting biomarker levels in the JP-8 
exposed workers. 
In GWAS, the use of genome-wide significance threshold makes few SNPs exceed 
the stringent statistical requirement and genetic markers that do not equal or exceed this 
conservative threshold are generally ignored or neglected unless the biological plausibility is 
very strong.  The reason for high threshold level of genome-wide significance (i.e., 5  10-7 – 
1  10-8) established in GWAS is to protect against the probability of a false-positive finding 
(O'Berg 1980; Risch and Merikangas 1996; Wolff et al. 1993) caused by multiple testing.  
Meanwhile, it also necessitates careful consideration of the power to detect the effect size in 
the GWAS.  Generally, the susceptibility alleles discovered are common and each allele 
confers a small contribution to the overall risk for the complex disease like cancer.  For 
nearly all regions conclusively identified by GWAS, the per allele effect sizes estimated are 
odds ratios <1.5 (Hindorff et al. 2009).  The mechanism by which these genetic variations 
have their effect on phenotype is not clear (Lee et al. 2006; Rioux et al. 2001; Yue and Moult 
2006).  In our study, the use of GWA allowed to rank the significant associated SNPs with 
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both skin NKAs, and the use of MLRMs including 10 SNPs with the lowest P-values 
provided one way to construct a final exposure model and investigate the contributions of 
multiple SNPs to biomarker levels.  The pathway and network analyses of multiple SNPs 
associated genes in the final models provide one way to identify biological processes that 
may be critical to determine the observed biomarker levels among exposed workers, without 
missing important pathways due to stringent threshold. 
Current analysis paradigms often ignore knowledge in regard to disease pathobiology.  
Further, the linear modeling framework in GWAS ignores the genomic and environmental 
context (Moore et al. 2010).  Environmental factors have been elusive in GWAS (Vineis et al. 
2009).  Identifying the gene and environment interactions will be difficult in GWAS case-
control studies given the low prevalence of exposures in large, often multicenter 
epidemiological studies.  The investigation of the potential predicted interactions between 
environment (extrinsic), individual genetic susceptibility (intrinsic), and the biological 
outcome (phenotype) in occupational exposure studies as described here, may provide an 
effective strategy and approach to identify human gene-environment interactions.  The 
environmental exposure is more prevalent and assessed with greater quantitative accuracy in 
a well-characterized sample population than in population or hospital-based case-control 
studies commonly conducted in GWAS performed to date (Vlaanderen et al. 2010).  Both 
environmental and genetic component contributions may vary depending upon the phenotype 
and the quantitative nature of the phenotype.  Identifying all possible contributing elements 
(environmental and genetic) to the phenotype is critical to explain all the variance in the 
phenotype, but practically, we may only be able to determine the greatest size effects in small 
well-defined populations.  Genetic and epigenetic factors present in a population that may 
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have significant size effects include heritable variation in traits that may not be associated 
with exposure to xenobiotics.  For example, heritable differences in blood pressure (essential 
hypertension) and respiratory rate and capacity may strongly influence the absorption, 
distribution, and clearance of metabolites (biomarkers) and may even be greater than the 
effects of metabolism.  This may especially be the case for tissues with limited phase 1 and 2 
metabolism, like the skin where metabolism may be restricted to the suprabasal cell layer of 
the epidermis. 
Allele frequency differences among different populations can cause confounding 
results in association study.  Since the study population was not ethically fully homogeneous, 
self-reported ethnicity was investigated to see if it contributed to skin NKA levels.  The 
MLRM results showed ethnicity was only significant for 2NKA and TNKA but not for 
1NKA level.  The SNP association test therefore was controlled for ethnicity only for 2NKA 
and TNKA level, not for 1NKA level.  We also made a quantile-quantile plot of association 
results for individual SNPs with skin NKA levels (Figure 2.3).  No significant deviation from 
the expected distribution of P-values of the tests for all SNPs, indicating no population 
stratification artifacts in our data.  In the future, we may use principal component analysis 
(PCA) (Patterson et al. 2006; Price et al. 2006) to correct potential population stratification.  
PCA with ENGENSTRAT has been used for GWAS for population structure.  The 
advantages of PCA include providing the most useful description of within-continent genetic 
variation, insensitive to the number of axes inferred, and computationally tractable on a 
genome-wide scale (Price et al. 2006). 
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Figure 2.3 Quantile-quantile plots of genome-wide association analysis of the observed 
versus expected –log10P values. The results of observed association between the 
quantitative skin naphthyl-keratin adduct levels are plotted against the 184153 
SNPs and the expected distribution of the –log10P under null hypothesis of no 
association (dash line 95% confidence level). 
 
Our sample size was small compared with a typical GWAS case-control study aimed 
to map disease marker.  The small effect size of complex diseases requires larger sample size 
to get enough statistical power.  However, our study population is well defined in that 
specific quantitative environment characteristics were measured (such as dermal and 
inhalation exposure data) and the exposure was prevalent and assessed with a great accuracy.  
Furthermore, intermediate quantitative traits were used instead of binary disease status, 
which is more objective (less misclassification), more informative, and can increase 
statistical power several fold (Potkin et al. 2009b).   Nevertheless, large sample size would 
provide more power with well-defined and quantitative traits. 
In summary, in GWA with 180,000 SNPs tested for significance at the 1% level of 
confidence, 1800 of these SNPs tested may be either false positive or false negative.  By 
using multiple levels of testing for significance of association, we aimed to reduce the risk of 
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selecting false positives by further testing groups of highly associated candidate genes by 
testing for gene-gene interactions in the curated literature.  Three predicted networks were 
obtained that suggest these SNP variants are highly associated with regulation of cellular 
processes and homeostasis and that may provide targets for adduction by naphthalene 
electrophilic metabolites. The biological functions of SNP associated genes must be validated 
by genetic and molecular analysis.  For example, the relationship between KLF6 and 
KRT1/KRT10 can be tested using miRNA knockdown of KLF6 in human skin tissue 
constructs and the exposure to relevant exposure levels to naphthalene.  Also, a potential 
strategy is a two-stage design and independent replication of samples to confirm study 
findings (Collins 2009).  Two-stage design and replication of the initial findings in follow-up 
studies can reduce the false-positive results and artifacts of the technique if a different 
analytical technique is applied in a second matched set of well-characteristic samples.  
However, replication is not easily achievable in that the populations are exposed to very 
different levels (i.e., not many other populations with similar levels of environmental 
exposure) (Vineis et al. 2009).  To conclude, this study should be regarded as a discovery 
study that can generate new hypotheses on the biological functions of potential genetic 
factors affecting biomarker levels.  Ultimately, only independent replication of these studies 
with increased sample size and/or functional validation of the candidate gene allelic variants 
will provide proof. 
2.6 Conclusions 
To our knowledge, this is the first study where individual differences in genetic 
polymorphism markers (i.e., SNPs) were investigated along with quantitative biomarker 
levels (i.e., NKA) measured in exposed workers using an association study tandem with 
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MLRM.  This study provides the methods and strategy to investigate the role of individual 
genetic variations in quantitative assessment of biomarker levels in small well-characterized 
worker population.  Further, this study provides evidence that individual genetic differences 
and the impact of personal and workplace factors on the measured biomarker levels should 
not be ignored when investigating factors (personal and environmental) that may affect the 
outcome in epidemiological studies.  Thus, the systemic exposure levels (parent compound or 
metabolite levels of xenobiotics) can be used as intermediate quantitative traits when 
investigating association between dose-response relationship and individual susceptibility to 
disease.  It is imperative that the sources of individual genetic variations will be accounted 
for in future epidemiological and exposure assessment studies that utilize biomarkers of 
exposure and/or effect to shed light on the exposure-disease relationship.  Studies, which 
include individual genetic markers as variance components, have potential to provide 
mechanistic insight into the etiology of disease, to identify susceptible subpopulation with 
respect to exposure, and provide useful input in setting exposure limits by taking into account 
individual susceptibility to adverse health effects. 
 
  
 
CHAPTER 3.  PAPER II: SINGLE NUCLEOTIDE POLYMORPHISMS 
ASSOCIATED WITH URINARY BIOMARKER LEVELS IN WORKERS EXPOSED 
TO JET FUEL 
Rong Jiang, John E. French, Vandy I. Stober, Mary Ann Butler, Fei Zou, Yi-Chun E. Chao, 
Stephen M. Rappaport, Berrin Serdar, Peter Egeghy, and Leena A. Nylander-French 
(manuscript) 
3.1 Abstract 
Recent gene-environment interaction studies in molecular epidemiology have not 
used genome wide association and detailed individual personal and environmental or 
occupational factors as variables in exposure-assessment statistical models.  Here, we 
investigated individual differences in single nucleotide polymorphisms (SNPs) as genetic 
markers associated with urine biomarker levels measured in workers exposed to jet fuel using 
PLINK and multiple linear regression models (MRLM).  In candidate-gene analysis, one 
SNP related to AHR was associated with urine 1-naphthol level (Bonferonni P=0.040).  The 
MRLM model including four significant covariates (dermal exposure, end-exhaled breath 
level, exposure time, and smoking) and the AHR related SNP explained 53% of the total 
variation in the 1-naphthol level.  In genome-wide analysis, the most significant associations 
for 1-, 2-, and total naphthol levels were at P-levels ≥ 9.3510-7.  The relative contributions 
of the significant SNPs to 1-, 2-, and total naphthol levels reached 50%, 49%, and 40%, 
respectively.  Pathway and network analyses indicated genes involved in the control of 
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thyroid hormone metabolism, which may be associated in homeostatic mechanisms affecting 
the mass movement of naphthalene metabolites into the cells of tissues.  We report here a 
method and strategy to investigate the role of individual genetic variation in the quantitative 
assessment of urine biomarker levels in a small well-characterized exposed worker 
population.  These tools have the potential to provide biological plausibility to explain the 
relevance of their impact on the biomarker level, mechanistic insight into the etiology of 
exposure related disease, and to identify susceptible subpopulation with respect to exposure.. 
3.2 Introduction 
Metabolism and toxicokinetics of xenobiotics may be altered based upon the 
exposure level that also influences the observed biomarker levels.  Individual genetic 
differences may lead to differences in activation/detoxification capacity that result in 
different levels of metabolites (e.g., urine metabolites), tissue distribution and elimination, as 
well as heritable differences in physiological function (blood pressure, heart rate, respiratory 
rate, etc.) that indirectly contribute to observed differences in toxicity, associated health 
effects, and the etiology of disease (resistance or susceptibility to disease) (Christiani et al. 
2008).  Current studies have shown that the interactions between environmental factors and 
genetic are critical to disease risk (Christiani et al. 2008; Vineis et al. 2009; Vlaanderen et al. 
2010).  Therefore, the direction of research in this area should be towards investigating the 
genetic basis of individual susceptibility to the exposure of various environmental hazards.  
Inclusion of the individual genetic variations in exposure assessment models may allow us to 
identify susceptible subpopulations with respect to workplace exposure, and provide useful 
input in setting exposure limits by taking into account individual susceptibility to adverse 
health effects in the occupational environment.  Thus, it is important to investigate the role of 
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individual genetic differences as a potential modifier in exposure assessment models of small 
well-characterized populations. 
Single nucleotide polymorphisms (SNPs) are the commonest and simplest form of 
human genetic variations, and new dense genotyping and sequencing methods along the 
allelic frequency of SNPs makes it possible to identify SNPs highly associated with 
quantitative biological phenotypes.  SNP association test can be performed to discover 
genetic variants that may give rise to a variation in a phenotype under investigation.  We 
postulate that it will be more informative to map intermediate steps associated with the 
disease processes (i.e., intermediate phenotypes), rather than use the binary case/control 
disease status with genetic marker loci (Chen et al. 2008; Emilsson et al. 2008; Keller et al. 
2008; Kim and Xing 2009; Kim et al. 2006).  The intermediate quantitative traits are more 
directly influenced by the genetic variations and thus provide detailed insight to the 
relationship between genetic variations and toxicity and/or disease phenotype.  Furthermore, 
the use of binary outcome decreases the resolution of the association substantially since large 
variability in outcome is not captured using dichotomous case-control variables, especially in 
an exposure assessment study.  A systemic exposure level (e.g., urine metabolite level) may 
be used as an intermediate quantitative trait when investigating association between 
biomarker level and individual susceptibility to toxicity and/or disease to improve the 
resolution compared to only using binary disease outcomes. 
The genetic variations have been reported to be associated with toxicokinetics of 
naphthalene and polycyclic aromatic hydrocarbons (PAHs), in general.  CYP2E1 and GSTM1 
have been reported to play an important role in metabolism of naphthalene among coke oven 
workers (Nan et al. 2001).  The urine 2-naphthol concentrations were observed to be higher 
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in worker with c1/c1 genotype of CYP2E1 than those with c1/c2 or c2/c2 genotype.  The 
levels of 2-naphthol were also higher in GSTM1 null workers than in GSTM1 positive 
workers.  CYP1A1*2 allele has been considered as a risk marker for PAH-related cancers 
associated with occupational exposure due to its greater capacity to activate PAHs (Lee et al. 
2001; Nerurkar et al. 2000).  Mixed-function oxygenases have been shown to be expressed in 
the liver during the metabolism of PAH: CYP1A1 (Kim et al. 2004; Lee et al. 2001), 
CYP1A2 (Castorena-Torres et al. 2005; Kim et al. 2004), CYP1B1 (Kim et al. 2004), 
CYP2E1 (Farin et al. 1995; Nan et al. 2001), CYP3A5 (Gabbani et al. 1999; Piipari et al. 
2000).  Conjugating enzymes, such as GSTM1, are also highly expressed in this tissue 
(Gabbani et al. 1999; Godschalk et al. 2001; Lee et al. 2001; Nan et al. 2001).  The 
expression of various genes related to antioxidant responses and detoxification, including 
those for glutathione-S-transferase (GST) and cytochrome P450 (CYP) proteins, were 
upregulated after exposure to JP-8 (Espinoza et al. 2005).  The functional status of these 
enzymes and their relative contribution to the metabolites may be critical to the 
understanding of individual variations in responses to jet fuel exposure.  In addition to these 
metabolic enzymes, other gene expressions in regulatory regions are altered after exposure of 
jet fuel.  For example, genes involved in basal transcription and translations were upregulated 
in human epidermal keratinocytes, whereas genes related to DNA repair were mostly 
downregulated (Chou et al. 2006).  Genes coded for growth factors, apoptosis, signal 
transduction, and adhesion were also altered (Chou et al. 2006). 
We previously reported on the contribution of individual differences in genetic 
polymorphism markers (i.e., SNPs) to the tissue specific quantitative biomarker levels (skin 
naphthyl-keratin adducts) measured in small well-characterized exposed worker population 
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using an association study tandem with multiple linear regression modeling (Jiang et al. 
manuscript).  We also provided evidence that individual genetic differences and the impact of 
personal and workplace factors on the measured biomarker levels should not be ignored 
when investigating factors (personal and environmental) that may affect the outcome in 
epidemiology studies (Jiang et al. manuscript).  Here, our goal was to investigate the relative 
contribution of individual genetic differences associated with urine biomarker levels (i.e., 
systemic exposure biomarkers) in this same worker population in order to account for the 
contribution of both dermal and inhalation exposure routes. 
3.3 Methods 
3.3.1 Study population 
Exposure data was available from the assessment of dermal and inhalation exposures 
to jet propulsion fuel 8 (JP-8) in the personnel at six U.S. Air Force (USAF) bases in the 
continental United States (Chao et al. 2005; Chao et al. 2006; Egeghy et al. 2003).  Workers 
who routinely worked or were exposed to JP-8 were recruited with informed consent from 
active duty USAF personnel.  Approval for human subject use was obtained from the 
institutional review board for the USAF and for each of the participating investigators, and 
the study complied with all applicable U.S. requirements and regulations. 
While 339 USAF personnel were enrolled in the overall project, 124 fuel-cell 
maintenance workers who were monitored for both dermal and inhalation exposure were 
included in this study.  Workers in this study included those who entered the plane‘s fuel cell 
and performed maintenance tasks including tank door removal, bolt removal, foam removal, 
foam replacement, fuel tank cleaning, depuddling, repairs, and inspections (referred to as 
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entrants).  Also included were attendants and runners who worked outside the fuel tank to 
assist entrants (e.g., foam removal) and other field workers who performed maintenance with 
occasional contact with JP-8.  Work diaries for each worker were recorded during the survey, 
including detailed information on work tasks and durations.  Questionnaires were collected 
after work shift to obtain the information on demographic factors, including job tasks, the use 
of personal protective equipment (PPE), smoking status, and other work related 
characteristics. 
3.3.2 Urine Biomarkers 
Naphthalene was used as a marker for exposure to JP-8 (Chao et al. 2005; Chao et al. 
2006; Egeghy et al. 2003); therefore, the two metabolites of naphthalene, 1-naphthol (1NAP) 
and 2-naphthol (2NAP), were used as urine biomarkers.  Collection and analyses of urine 
samples have been described elsewhere (Serdar et al. 2003).  Briefly, naphthalene, 1NAP, 
and 2NAP levels were determined in urine samples collected from the workers immediately 
after work shift.  Naphthalene level in urine was measured via headspace solid-phase 
microextraction followed by gas chromatography-mass spectrometry (GC-MS) analysis 
(Serdar et al. 2003).  For analysis of 1NAP and 2NAP, urine samples were hydrolyzed, 
extracted, derivatized, and analyzed by GC-MS.  Total urine naphthol (TNAP) level was 
calculated by summing up the levels of 1NAP and 2NAP. 
3.3.3 Dermal and Inhalation Exposure 
Dermal tape-strip samples and end-exhaled breath samples were collected for 
quantification of dermal and inhalation exposure to naphthalene, as a marker for JP-8 
exposure (Chao et al. 2005; Chao et al. 2006; Egeghy et al. 2003).  In brief, for each worker, 
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three body regions with potential greatest dermal exposure to JP-8 were selected for tape-
strip sampling after work shift (Chao et al. 2005).  Three sequential tape-strips at each region 
were collected.  Naphthalene was extracted from the tape by acetone and analyzed by GC-
MS (Chao et al. 2005).  Dermal exposure was adjusted for the surface area of the particular 
region sampled in order to estimate the regional dermal exposure to naphthalene.  The whole-
body dermal exposure was calculated by summing the estimated regional dermal naphthalene 
concentrations of the three sampled regions and by conservatively assuming that no exposure 
to the other unsampled regions occurred (Chao et al. 2005).  End-exhaled breath samples 
were collected using 75-cm
3
 glass bulbs immediately after the work shift (Egeghy et al. 
2003).  The levels of naphthalene in the breath samples were analyzed by thermal desorption 
followed by GC-MS with photo ionization detection (Egeghy et al. 2003). 
3.3.4 Genotyping and Calling 
Blood (10 ml) was collected into EDTA vacutainer tube from each worker at the end 
of the work shift and shipped on Blue Ice

 (Rubbermaid, Atlanta, GA) to maintain a 
temperature of 4°C to arrive into the laboratory within 24 h.  Samples were then aliquoted 
into 1.8 ml cryovials and stored in –70°C until analysis.  DNA was isolated using Puregene 
DNA extraction kit (Gentra, Minneapolis, MN) from 0.5 ml of whole blood and quantified 
using a NanoDrop (Thermo Fisher Scientific).  Concentration of DNA or further clean up for 
increased purity was carried out by vacuum centrifuge (Savant Instruments Inc., Holbrook, 
NY) or ethanol precipitation, respectively.  Once the DNA was obtained at a concentration 
greater than 50 ng/µl with a purity of 1.8 or higher, a gel was run to verify that DNA was 
intact.  DNA was then processed by Affymetrix protocol for analysis using the GeneChip
®
 
Human Mapping 250k StyI SNP array set (Affymetrix, Santa Clara, CA) using a StyI 
 65 
 
digestion.  In brief, 250 ng of DNA was digested using StyI restriction enzyme.  An adaptor 
was ligated to the digested fragments and PCR performed using the added adapter sequences 
as primers.  PCR products were cleaned and normalized prior to fragmentation and labeling 
with the fluorochrome.  Arrays and samples were submitted to the UNC-CH Affymetrix Core 
for hybridization, washing, and reading of the array using the Affymetrix platform equipment 
to obtain individual SNP data. 
Array images were acquired by scanning each array and raw DAT-image files were 
generated in GeneChip
®
 Operating System (GCOS) software at UNC-CH Affymetrix Core.  
Each raw DAT image was processed by GCOS into CEL file, which was later run in 
Affymetrix Genotyping Console 3.0.1 using BRLMM algorithm to genotype ~238,000 SNPs 
for each worker.  Each SNP genotype was generated as AA, AB, BB, or ―no call‖ if the 
confidence value is less than 0.5. 
3.3.5 Data Cleaning 
Among 124 workers, one worker was removed due to missing urine biomarker data 
while three workers were excluded due to low genotype rate (missing genotype rate per 
person >10%).  In addition, 28,592 markers with low genotype rate (missing genotype per 
SNP >10%), 17,525 SNPs with less than 1% minor allele frequency (MAF <0.01), and 5,994 
SNPs with Hardy-Weinberg departure (P < 0.001) were excluded from the association test.  
The SNPs on X chromosome were excluded for simplification.  After data cleaning, we 
attained a set of 120 exposed workers with 184,846 SNPs for association tests with urine 
biomarker levels.  The average call rate was 98.1%. 
 66 
 
3.3.6 Statistical Analyses 
All descriptive statistics of the levels of urine naphthalene and its metabolites (1NAP, 
2NAP, and TNAP) as well as naphthalene exposure (dermal and breath) levels were 
determined using SAS 9.2 (SAS Institute, Cary, NC).  The difference between 1NAP and 
2NAP levels was determined using Student‘s t-test. 
SNP Association Analyses 
SNP association analyses between SNP alleles and urine 1NAP, 2NAP, and TNAP 
levels were performed using PLINK version 1.06.  Dermal and breath naphthalene as well as 
urine biomarker levels were log-transformed to meet the normal distribution assumption.  
Additive effect was used for SNP allele dosage and coded as 0 = AA, 1 = AB, 2 = BB; in this 
way, the mean value of biomarker level increases with the variant allele frequency.  SNP 
associations were investigated using candidate-gene and genome-wide approaches 
controlling for important personal and workplace factors (i.e., covariates).  SNPs associated 
with each corresponding urine metabolite level were selected as potential independent 
variables in the exposure assessment model containing the significant personal and 
workplace covariates in order to investigate the relative contribution of individual genetic 
variation to the urine biomarker levels. 
Multiple linear regression models (MLRMs) were first developed using SAS to 
determine the significant personal and workplace factors ( = 0.1) that may confound 
association between SNPs and urine biomarker levels.  The general form of a linear 
regression model is given as follows: 
 
  

Yi  0   p X ip qCiq i
q1
Q

p1
P
  (1) 
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where Yi represents the natural logarithm of the urine biomarker level of the i
th
 worker, Xip 
represents the p
th
 natural logarithm of the dermal and inhalation naphthalene level for the i
th
 
worker, Ciq represents the q
th
 covariate value for the i
th
 worker (i.e., personal and workplace 
factors including ethnicity, smoking status, job type, PPE, etc.), p and q represent the 
regression coefficient for p
th
 exposure level, and q
th
 covariate, respectively, 0 is the intercept, 
and i is the random error for the i
th
 worker.  The STEPWISE model selection was used in 
PROC REG to determine model 1.  Possible collinearity problems were investigated using 
eigenvalue analyses, condition indices, and variance inflation factors.  Possible outliers were 
examined using studentized residuals.  Residual analysis was performed to check if the fitted 
models meet all assumptions. 
Next, association between SNP allele type and urine metabolite levels was tested 
using PLINK while controlling for covariates determined in the previous step.  The general 
form of the linear model in PLINK is given as follows: 
 
  

Yi  0  gSig   p X ip  qCiq i
q1
Q
  (2) 
where Sig represented the g
th
 tested SNP type for the i
th
 worker as individual genetic data; and 
g represented the coefficient for g
th
 SNP.  Everything else remained the same as in model 1.  
One SNP association was tested at a time controlling for covariates using model 2. 
We began the analysis using SNPs as genetic markers to identify association with 
candidate genes.  The selection of these candidate genes has been described previously (Jiang 
et al. manuscript), and was based on their known or expected functional and/or regulatory 
roles in the metabolism and toxicokinetics of naphthalene and or similar chemicals (i.e., 
PAHs) as indicated in the peer-reviewed published literature.  Thus, candidate-gene analysis 
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(CGA) was performed using 498 SNPs on 35 candidate genes (Table 3.1).  Bonferroni 
correction and permutation (N = 10,000) were used to correct multiple testing (overall α = 
0.1). 
After CGA, we performed genome-wide analysis (GWA) to probe for unknown SNPs 
that may not be a candidate gene for naphthalene metabolism and toxicokinetics.  GWA was 
used to identify any SNPs significantly associated with 1NAP, 2NAP, and/or TNAP levels 
regardless of mechanism.  The overall level of significance used was 0.1.  Genome-wide 
plots were generated in R using package ―gap‖ (Zhao 2007) for SNPs associated with each 
skin NKA level. 
Table 3.1 Candidate genes (N = 35) and the number of SNPs (N = 498) tested for 
association with urinary biomarker levels in fuel-cell maintenance workers using 
candidate-gene analysis. 
Gene Number of SNPs  Gene Number of SNPs  Gene Number of SNPs 
AHR 67  CYP2A6 4  EPHX1 4 
AKR1C1 19  CYP2B6 4  EPHX2 19 
AKR1C2 22  CYP2C18 1  GSTM3 2 
AKR1C3 22  CYP2C19 9  GSTM5 2 
AKR1C4 29  CYP2C8 10  GSTT1 1 
ARNT 2  CYP2C9 9  GSTT2 6 
ARNT2 47  CYP2D6 0  NQO1 1 
CRABP1 8  CYP2E1 13  SOD1 7 
CYP1A1 3  CYP3A4 1  SOD2 64 
CYP1A2 29  CYP3A5 2  SOD3 18 
CYP1B1 38  CYP3A7 3  SRD5A2 11 
CYP26B1 51  CYP4B1 10    
Note: The total number of SNPs is 537 in this table, because some SNPs are shared by more than one 
gene, only 498 independent SNPs were tested on 35 genes. 
Exposure Modeling 
To investigate the proportion of explained variance in individual urine biomarker 
levels, we examined the relative contribution of individual SNP markers potentially involved 
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in naphthalene metabolism and toxicokinetics and the contribution of personal (e.g., personal 
protection, smoking, etc.) and workplace (e.g., job, task, work environment) factors due to 
dermal and inhalation exposure to jet fuel.  MLRM were developed using SAS to construct a 
final exposure model and the significance was evaluated at -level of 0.1.  Once significant 
SNPs associated with urine biomarker levels were identified from CGA and GWA, these 
SNP types were selected as potential independent variables for development of the final 
model and computation of the relative contribution of these SNPs to the urine biomarker 
levels along with the significant personal and workplace factors.  The general form of 
multiple linear regression model was modified to: 
 
  

Yi  0   p X ip qCiq  gSig i
g1
G

q1
Q

p1
P
  (3) 
More than one SNP and significant covariates were selected as potential independent 
variables.  STEPWISE selection was used in PROC REG to determine regression model 3 
and model analysis was performed using the same methods as in model 1. 
The relative contribution of each predictor in the final regression models were 
determined by the proportionate contribution that each predictor made to the regression 
model R
2
 using Pratt index, which is the product of its estimated standardized regression 
coefficient and the simple correlation between that predictor and the outcome variable (Chao 
et al. 2008; Pratt 1987). The relative contribution considered in this investigation is the 
dispersion importance, i.e., the proportion of the variance in outcome variable accounted for 
each predictor in the regression model. 
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3.3.7 Bioinformatic Analysis of Highly Associated SNPs and Network Interactions 
The bioinformatics of all identified SNPs associated with urine biomarker levels by 
SNP association test and MLRMs were investigated and the curated sequence identification, 
location, and gene ontology established using NCBI Entrez Gene 
(http://www.ncbi.nlm.nih.gov/snp), Ensembl BioMart (http://www.biomart.org), and/or 
UCSC gene browser (http://genome.ucsc.edu).  The potential for SNP associated gene 
interactions affecting the biomarker levels was tested for statistical significance by 
MetaCore integrated knowledge database and software suite for pathway analysis 
(GeneGo.com) using their proprietary database of hand-curated peer-reviewed literature and 
statistical analysis of network interactions (Brennan et al. 2009; Chang 2009).  Highly 
relevant gene functions were corroborated by further literature analysis of the predicted 
associations (formula available from MetaCore, GeneGo.com by request).  Ultimately, the 
functional significance of the candidate genes must be established by further genetic and 
molecular analysis using appropriate model systems. 
Network analysis of genome-wide association studies (GWAS) involving SNPs (or 
any other forms of genetic variation) may be described in 3 steps: (1) compiling the SNP data 
associated with appropriate gene identifiers; (2) weighting of SNPs according to their relative 
contribution to the observed outcome; and (3) network analysis methods (qualitative and 
quantitative) (Torkamani and Schork 2009).  The prioritization of associated genes and/or 
sequences and the impact on the interactions with particular pathways or predicted networks 
can be evaluated by analyzing the basic components of the network from the curated 
literature (Chang 2009; Metacore, GeneGo.com).  We performed a final quality control 
step by randomly evaluating critical protein-protein interactions by analysis of published 
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results to aid in the determination of the strength of the evidence for the proposed 
interactions and predicted networks. 
3.4 Results 
3.4.1 Study Population and Exposure Measurements 
After data cleaning, there were 120 workers and 184,846 SNPs available for analyses.  
The workers included 111 males (92.5%) and 9 females (7.5%) of whom 103 were 
Caucasians (85.8%), 17 were non-Caucasians (8 African-American, 5 Hispanic, 4 Asian or 
others; 14.2%), and 52 were smokers (43.3%).  The average age of the workers was 24.5 ± 
5.0 years and ranged 18 – 40 years. 
The measured urine naphthol and naphthalene levels as well as dermal and end-
exhaled breath naphthalene levels are presented in Table 2.  The level of 2NAP was 
significantly higher (P < 0.0001) than the level of 1NAP among the workers.  Covariates 
dermal exposure, exposure time, and smoking were significantly associated with all urine 
naphthol levels (all P-values < 0.05).  However, end-exhaled breath level was significantly 
associated with 1NAP (P = 0.0002) and TNAP (P = 0.012) but not with 2NAP level.  Due to 
missing inhalation exposure and exposure time data, only 112 subjects were included in these 
models.  In both GCA and GWA, we performed SNP association analysis by controlling for 
covariates dermal exposure, end-exhaled breath level, exposure time, and smoking for 1NAP 
and TNAP levels while for 2NAP level we controlled for covariates dermal exposure, 
exposure time, and smoking. 
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Table 3.2 Geometric means (GM) and geometric standard deviations (GSD) of urine 
naphthol and naphthalene levels as well as dermal, breathing-zone, and end-
exhaled breath naphthalene levels measured in the U.S. Air Force personnel 
exposed to jet fuel. 
Indicator of exposure n GM GSD Min Max 
Urine 1-naphthol (ng/L) 120 16800 3.30 483 127000 
Urine 2-naphthol (ng/L) 120 24300 3.17 485 31500 
Urine total naphthols (ng/L) 120 43400 3.06 969 398000 
Urine naphthalene (ng/L) 120 280 9.35 0.432 39600 
Dermal naphthalene (ng/m
2
) 120 2030 9.91 100 5090000 
Breathing-zone naphthalene (ng/m
3
) 115 1780 2.66 330 15800 
End-exhaled breath naphthalene (ng/m
3
) 115 253000 5.90 670 3910000 
n = number of subjects 
3.4.2 SNP-Biomarker Association  
The quantile-quantile plots of the association results for individual SNPs with urine 
naphthol levels are presented in Figure 3.1.  No significant deviation was observed from the 
expected P-value distributions of the tests for all SNPs, indicating no population stratification 
artifacts in our data. 
 
Figure 3.1 Quantile-quantile plots of genome-wide association analysis of the observed 
versus expected –log10P values. The results of observed of association between 
the quantitative urine naphthol levels are plotted against 184846 SNPs and the 
expected distribution of the –log10P under null hypothesis of no association 
(dash line 95% confidence level). 
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Based on the corrected P-values at -level 0.1 used in biomarker studies, one SNP 
(rs590197, MAF=0.2545) on chromosome 7 related to candidate gene AHR was significantly 
associated with 1NAP levels (Bonferroni P = 0.040, permutation P = 0.052) when 
controlling for dermal exposure, end-exhaled breath level, exposure time, and smoking.  No 
SNPs on candidate genes were observed to be significantly associated with 2NAP or TNAP 
level.  A multiple linear regression models for 1NAP levels was constructed that included the 
significant SNP (rs590197) related to AHR, dermal exposure, end-exhaled breath level, 
exposure time, and smoking.  This model explained about 53% of the total variation in 1NAP 
level (R
2
 = 0.526).  As described by this model, the relative contribution of this SNP was 
13%, which was greater than the contribution of smoking and exposure time. 
The genome-wide plots in Figure 3.2 present SNP association results for each urine 
naphthol level.  No single SNP reached genome-wide significance (i.e., 5  10-7 – 1×10-8) 
(Chung et al. 2010) associated with urine naphthol levels.  The most significant associations 
for 1NAP, 2NAP, and TNAP levels were at P = 5.23 × 10
-6
 (rs185635 on chromosome 6), P 
= 7.18 × 10
-7 
(rs9955192 on chromosome 18), and P = 9.35 × 10
-7 
(rs9955192 on 
chromosome 18), respectively.  The locations and the patterns of significant SNPs associated 
with urine naphthol levels varied for 1NAP, 2NAP, and TNAP (Figure 3.2). 
We selected 10 SNPs with the lowest unadjusted P-values along with corresponding 
significant covariates to investigate their effects and relative contributions to each urine 
biomarker level using MLRM.  The significant SNPs in the final models and their relative 
contributions to urine naphthol levels are shown in Table 3.3.  There were 5, 7, and 6 SNPs 
of the 10 SNPs that remained as significant in the final model for 1NAP, 2NAP, and TNAP, 
respectively (Table 3.3).  These specific models explained 82%, 75%, and 77% of the total 
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variation (the value of the R
2
 in each model) in predicting the level of 1NAP, 2NAP, and 
TNAP, respectively.  Within the context of these models, the total relative contribution of all 
SNPs to 1NAP, 2NAP, and TNAP level reached 50%, 49%, and 40%, respectively (Table 3.3; 
the sum of the relative contribution of each SNP associated with each urine naphthol level). 
  
 75 
 
 
 
 
Figure 3.2 Manhattan plots for the associations between the –log10P values of the urine 
naphthol levels controlled for covariates for 184846 SNPs and the SNP physical 
chromosome location. 
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Table 3.3 Regression models for urine naphthol levels measured in the fuel-cell 
maintenance workers using genome-wide analysis. 
Biomarker n R
2
 Predictor 
Parameter  
Estimate 
Standard  
Error 
P-value 
Relative 
 Contribution 
(%) 
1NAP 91 0.821 Intercept -0.051 0.787 0.949  
   Exposure time 0.002 0.001 0.085 4.13 
   Dermal exposure 0.110 0.033 0.001 12.69 
   Breath 0.474 0.073 <0.0001 28.81 
   Smoking 0.409 0.112 0.001 4.56 
   rs185635 0.492 0.098 <0.0001 12.92 
   rs4730197 -0.545 0.119 <0.0001 12.31 
   rs1357189 0.645 0.149 <0.0001 12.20 
   rs9317191 0.579 0.116 <0.0001 6.46 
   rs16965312 1.025 0.287 0.001 5.94 
2NAP 111 0.753 Intercept 7.430 0.470 <0.0001  
   Exposure time 0.004 0.001 0.0003 10.10 
   Dermal exposure 0.231 0.026 <0.0001 32.67 
   Smoking 0.598 0.117 <0.0001 8.08 
   rs2105367 -0.322 0.084 0.0002 10.27 
   rs10758510 -0.416 0.108 0.0002 9.59 
   rs2326227 0.282 0.089 0.002 8.00 
   rs9955192 0.384 0.112 0.001 7.84 
   rs929759 -0.272 0.108 0.013 6.08 
   rs7004326 -0.299 0.090 0.001 3.82 
   rs4321478 -0.622 0.286 0.032 3.55 
TNAP 97 0.773 Intercept 4.94906 0.55864 <0.0001  
   Exposure time 0.004 0.001 0.0003 10.76 
   Dermal exposure 0.194 0.033 <0.0001 27.51 
   Breath 0.277 0.078 0.001 16.20 
   Smoking 0.563 0.118 <0.0001 6.55 
   rs6911435 -0.267 0.078 0.001 8.04 
   rs9955192 0.338 0.113 0.004 7.84 
   rs10518700 -0.857 0.282 0.003 7.53 
   rs9317191 0.532 0.121 <0.0001 6.30 
   rs7004326 -0.364 0.087 <0.0001 5.15 
   rs6015369 0.236 0.111 0.036 4.13 
1NAP = 1-naphthol; 2NAP = 2-naphthol; TNAP = total naphthols (1NAP + 2NAP) 
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3.4.3 Bioinformatics 
The SNP genetic markers and their most likely associated cis-related genes, which 
were identified in the final exposure model for 1NAP, 2NAP, and TNAP levels based upon 
their significance and relative contribution to the observed biomarker phenotypes and the 
other highly significant predictors (shown in Table 3.3) are listed in Table 3.4.  Of the 14 
SNPs identified in common with 1NAP, 2NAP, and TNAP levels, 5 SNP genetic markers 
and their intragenic or cis-related intergenic sequence associated genes could be assigned to a 
predicted network of protein-protein interactions responding to naphthalene exposure.  Six 
markers and associated sequences could not be categorized as to function or assigned to a 
predicted network.  The remaining 3 markers could not be evaluated for association because 
of their likely association with theoretical genes that have not yet been investigated and 
functionally validated.  The protein-protein interactions identified for analysis primarily 
involve thyroid hormone family of nuclear receptors and their known downstream signaling 
events that affect cell metabolism, including lipid and membrane metabolism as well as the 
positive and negative regulation of cellular processes that are consistent with the absorption, 
clearance, and potential toxicity (inflammation, cell proliferation, etc.) of naphthalene 
metabolites.  Based upon the gene ontology enriched data sets and relationships established 
from the hand-curated published literature integrated into the Metacore knowledge data 
base, three networks are predicted for this population of individuals exposed to naphthalene 
and the observed biomarker of exposure (urine naphthol level). 
The predicted network A (P = 5.6 x 10
-14
), which includes critical interactions 
between variants of THRB/RXRA interaction, THRA, HDAC2, RARB, and FAM5C, is 
enriched for thyroid hormone regulation of cell and lipid metabolism (Figure 3.3A).  THRB 
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(thyroid hormone receptor, beta) and THRA (thyroid hormone receptor, alpha) encode 
nuclear hormone receptors for triiodothyronine that mediate the biological activities of 
thyroid hormone (Harvey and Williams 2002; Zhu and Cheng 2010).  Different thyroid 
hormone receptors may in part be functionally redundant and/or may mediate different 
functions of thyroid hormone.  SNPs or mutations in thyroid hormone receptors may produce 
hypomorphic variants that result in thyroid hormone resistance and goiter-like symptoms 
with normal or slightly elevated levels of thyroid stimulating hormone (TSH) (O'Shea and 
Williams 2002; Wan et al. 2005).  RXRA (retinoid X receptor, alpha) and RARB (retinoic 
acid receptor, beta) are nuclear receptors that mediate the biological effects of retinoids 
(retinoic acid, the biological active form of vitamin A), and retinoic acid-mediated gene 
activation affecting cell growth and differentiation (Ahuja et al. 2003; Khetchoumian et al. 
2008).  The HDAC2 histone deacetylase acts on lysine residues at the N-terminal regions of 
core histones (H2A, H2B, H3 and H4) (de Ruijter et al. 2003).  This protein forms critical 
transcriptional repressor complexes by associating with many different proteins, including 
YY1, a mammalian zinc-finger transcription factor.  Thus, HDAC2 plays an important role in 
transcriptional regulation, cell cycle progression, and development (Senese et al. 2007; 
Yamaguchi et al.).  The protein encoded by FAM5C (family with sequence similarity 5, 
member C) is highly conserved and predicted to be involved in negative regulation of the cell 
cycle.  No specific curated literature is available as to its function or target.  The interactions 
of this predicted network based upon this set of SNP variants and their likely associated 
genes and proteins are primarily associated with cell and lipid metabolism and responses to 
xenobiotic exposure. 
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The second predicted network B (P = 5.5 x 10
-16
) also identifies THRB, RXRB, and 
HDAC2 as potential key effector proteins along with PIK3CG (Figure 3.3B).  In this network, 
the responses to organic substance, organ development, response to chemical stimulus, and 
both positive and negative regulation of cellular process are enriched.  PIK3CG, 
phosphoinositide-3-kinase, catalytic, gamma polypeptide, converts phosphatidylinositol 4,5-
biphosphate to phosphatidylinositol 3,4,5-triphosphate.  This gene encodes a protein that 
belongs to the pi3/pi4-kinase family of proteins.  The gene product is an enzyme that 
phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring.  PIK3CG is 
an important modulator of extracellular signals, including those elicited by E-cadherin-
mediated cell-cell adhesion, which plays an important role in maintenance of the structural 
and functional integrity of epithelia (Rivard 2009).  Interestingly, the gene is located in a 
commonly deleted segment of chromosome 7q22.3, previously identified in myeloid 
leukemia patients (Kratz et al. 2002). 
In the predicted network C (P = 6.32 x 10
-8
) PIK3CG, THRB/RXRB, IBTK, BTK, 
RELA variants were identified (Figure 3.3C).  This network incorporates components of the 
first two predicted networks, plus the IBTK, an inhibitor of Bruton agammaglobulinemia 
tyrosine kinase, and RELA (p65 NF-kB subunit), which involves the main inflammatory 
pathway.  The protein encoded by IBTK gene binds to Bruton's tyrosine kinase (BTK) and 
downregulates BTK's kinase activity (Liu et al. 2001).  In addition, the encoded protein 
disrupts BTK-mediated calcium mobilization and indirectly negatively regulates the 
activation of NFKB transcription (Rayet and Gelinas 1999).  NFKB1 or NFKB2 binds to 
REL, RELA, or RELB, to form the active NFKB complex.  IKB proteins (NFKBIA or 
NFKBIB), which inactivate NFKB by binding and trapping NFKB in the cytoplasm inhibit 
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the NFKB complex.  Phosphorylation of serine residues on the I-kappa-B proteins by the 
kinases (IKBKA or IKBKB kinases) marks them for destruction via the ubiquitination 
pathway, thereby allowing activation of the NFKB complex (Ross et al. 2010; Thoms et al. 
2007; Tsai et al. 2008).  Negative regulation of cellular and biological processes, response to 
peptide hormone stimulus, protein amino acid phosphorylation, and intracellular signaling 
cascade are enriched in this network. 
In addition, a number of variants showed no network associations (Table 3.4).  The 
lack of association in these variants is likely due to the lack of observed interactions and 
functions in the published literature that compile the knowledge database for Metacore.  
SLC17A, TRIM38, FAM38B, FAM46A, and NPEPL1 (Table 3.4) were identified by full-
length transcripts from genome-wide human cDNA or chromosome specific analysis, but 
their functions have not yet been published.  The SLC17A, a member of the solute carrier 
family of transporters, may act as a solute carrier in the clearance of metabolites.  FAM46a 
has been associated with retinal disease (Lagali et al. 2002).  TRIM38 is a member of the 
tripartite motif (TRIM) family and may function similarly to TRIM24, which acts a co-
regulator of RAR mediated gene expression (Khetchoumian et al. 2008). CCDC99 (coiled-
coil domain containing 99) encodes Spindly prevents Dynein recruitment at the kinetochore 
and prevents premature cytokinesis (Gassmann et al. 2010).  Most important are the non-
coding RNAs, which have recently been identified as having significant effects on gene 
regulation and may affect the tissue specific expression of genes and their transcript splice 
variants. 
A number of non-coding RNAs were also identified that have not yet been adequately 
investigated and published.  These include ZFATAS, MIR296, MIR1273, and MIR585, 
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which are all likely involved in posttranscriptional regulation of gene expression.  ZFATAS, 
an antisense RNA (non-protein coding) involved in regulating the sense strand locus, zinc 
finger, and AT hook domain and susceptibility to autoimmune thyroid disease (Shirasawa et 
al. 2004).  MIR296, MIR1273, and MIR585 are non-coding RNAs that are involved in 
posttranscriptional regulation of gene expression (Makeyev and Maniatis 2008), but their 
specific targets have not yet been identified.  Together, these associated functions are all 
likely to control cell metabolism and affect naphthol transport and clearance by controlling 
the rate of available membrane availability through associated pathways. 
   
Table 3.4 SNP variants and genes associated with urine naphthol levels in fuel-cell maintenance workers as identified by genome-
wide analysis (GWA) and multiple linear regression modeling. 
Biomarker Chromosome SNP 
Build 37.1 
Position 
Alleles Associated Genes MAF 
GWA 
P-value 
1NAP 6p21.3 rs185635 25900164 C/T SLC17A2;TRIM38 0.204 5.23E-06 
 6q21 rs1357189 112518737 C/T HDAC2;LOC100287673 0.077 2.65E-05 
 7q22.3 rs4730197 100806330 A/C FLJ3603;PIK3CG 0.151 1.30E-05 
 13q12.11 rs9317191 4132274 C/T LOC40173;LOC646164 0.190 2.95E-05 
 15q21.3 rs16965312 30043071 A/C RPSAP55;MIR1273 0.025 3.69E-05 
2NAP 1q31.1 rs2105367 161286779 C/G FAM5C;LOC647132 0.413 5.07E-05 
 3p12.1 rs2326227 84769450 G/T LOC100130326;LOC100289598 0.321 3.14E-05 
 3p24 rs4321478 24724519 A/G THRB;RARB 0.029 3.22E-05 
 5q35 rs929759 163941142 A/G MIR585;CCDC99 0.231 4.14E-05 
 8q24.22 rs7004326 130926583 A/C ZFATAS 0.368 1.31E-05 
 9p13.1 rs10758510 38592156 C/G LOC100131630;LOC647051 0.188 5.11E-05 
 18p11.22 rs9955192 10617397 C/T FAM38B;LOC390831 0.203 7.18E-07 
TNAP 6q14.1 rs6911435 79965664 A/G FAM46A;IBTK 0.442 3.71E-05 
 8q24.22 rs7004326 130926583 A/C ZFATAS 0.368 2.15E-05 
 13q12.11 rs9317191 4132274 C/T LOC46164;LOC401730 0.190 1.55E-05 
 15q21.3 rs10518700 30045300 C/T RPSAP55;MIR1273 0.025 5.01E-05 
 18p11.22 rs9955192 10617397 C/T FAM38B;CCDC58P1 0.203 9.35E-07 
 20q13.32 rs6015369 54148304 G/T NPEPL1;MIR296 0.288 5.11E-05 
1NAP = 1-naphthol; 2NAP = 2-naphthol; TNAP = total naphthols (1NAP + 2NAP); MAF = minor allele frequency 
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Pathway Network Gene Ontology Processes P-Value zScore 
A THRB/RXRA, 
THRB, HDAC2, 
RARB, FAM5C 
Triglyceride metabolic process (37.0%; 3.12E-18), response to drug 
(55.6%; 7.68E-18), acylglycerol metabolic process (37.0%; 1.49E-17), 
neutral lipid metabolic process (37.0%; 1.86E-17), glycerol ether metabolic 
process (37.0%; 2.07E-17) 
5.56E-14 58.02 
B THRB, HDAC2, 
RARB,PIK3CG, 
THRB/RXRB 
Response to organic substance (58.7%; 1.05E-19), organ development 
(65.2%; 8.65E-17), negative regulation of cellular process (63.0%; 8.98E-
17), response to chemical stimulus (65.2%; 2.04E-16), positive regulation 
of cellular process (65.2%; 2.58E-16) 
5.50E-16 56.25 
C PIK3CG, 
THRB/RXRB, 
IBTK, BTK, RELA 
(p65 NF-kB 
subunit) 
Negative regulation of cellular process (75.9%; 1.10E-15), negative 
regulation of biological process (75.9%; 8.57E-15), response to peptide 
hormone stimulus (37.9%; 6.70E-13), protein amino acid phosphorylation 
(48.3%; 8.25E-13), intracellular signaling cascade (58.6%; 2.92E-12) 
6.32E-08 33.25 
Figure 3.3 Predicted MetaCore™ network interactions from 14 polymorphic SNP genetic markers associated with the urinary 
naphthol levels measured in the fuel-cell maintenance workers. 
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3.5 Discussion 
In this second SNP genetic association with quantitative biomarker level study in 
exposure assessment, we provide useful information and analysis of the impact of individual 
genetic variability on a systemic exposure biomarker (i.e., urine biomarker levels) among jet 
fuel exposed workers in occupational setting.  The quantitative trait of urine naphthalene or 
naphthol level could be regarded as an intermediate trait, which may have increased power 
for analyzing a small occupationally exposed population that should not be compared to 
genome wide association studies of binary case-control outcome that require large study 
populations.  Our aim was to identify potential SNPs associated with quantitative urine 
biomarker levels among workers exposed to JP-8, as well as to conduct a preliminary 
analysis to investigate the effect of individual genetic variation in explaining the variability 
of systemic exposure level together with other factors such as dermal and inhalation exposure 
level, smoking status, etc. 
We observed only one SNP (rs590197) related to AHR on the 35 candidate genes to 
be significantly associated with urine 1NAP level.  AHR, a cytosolic transcription factor, is 
involved in the induction of several phase I and phase II xenobiotic metabolizing enzymes 
(Nebert et al. 2000).  Although this AHR related SNP is located 161kb downstream from the 
gene-coding region, it may affect or be associated in some way with biological functions 
such as locus-control region and those regulatory sequences that affect gene expression, etc.  
The observed association between this SNP and urine 1NAP level indicates that individual 
genetic variations in AHR can contributed to the systemic level of naphthalene metabolites.  
This observation is supported by another study where AHR was observed to be associated 
with the urine of 1-hydroxypyrene level in PAH exposed workers after adjustment for 
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exposure, cigarettes smoked, etc., suggesting that AHR-mediated signaling contributes to 
individual susceptibility (Bin et al. 2008).  The failure to identify any other SNPs on 
candidate metabolism genes may indicate that variations in the metabolic genes do not have a 
significant indicative effect on urine biomarker level. 
The results of GWA showed that no SNP reached the genome-wide significance for 
urine naphthol levels although the P-values of the most significant associations for 1NAP, 
2NAP, and TNAP levels were very close.  The MLRMs, which included the 10 SNPs with 
the lowest unadjusted P-values along with the significant covariates, showed that these SNPs 
contributed significantly to urine naphthol levels in their respective models.  The final 
models including the SNPs explained more of the total variations in the level of 1NAP, 
2NAP, and TNAP than the models without these SNPs.  We recognize that the test 
association for a single SNP has limited utility and is insufficient to disclose the complex 
genetic structure of many common disease and biomarker levels among exposed subjects.  
Common diseases often arise from the joint action of multiple loci within a gene or joint 
action of multiple genes within a pathway (Luo et al. 2010).  Although each single SNP may 
confer only a small toxicity or disease risk, their joint actions are likely to have significant 
risk effects.  The pathway and network analysis allows us to better understand how these 
SNPs (either within genes or proximate genes) interaction with each other and function 
jointly as certain biological processes that may be critical to the determination of urine 
biomarker level among exposed workers. 
SNP genetic markers were highly associated with several predicted networks that 
emphasized the association with thyroid hormone regulation of cell and lipid metabolism and 
the positive or negative regulation of cell functions, including the cell cycle and cell 
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proliferation.  These highly significant predicted networks and the potential proteins with 
unknown function, and the non-coding RNA regulation of gene expression suggested from 
these SNP genetic marker associations indicate that urine levels of naphthol biomarkers may 
be treated as a quantitative trait.  The data further suggest that the association with thyroid 
hormone and the control of metabolism may be associated with individual differences in 
homeostatic mechanisms affecting the mass movement of naphthalene and naphthol 
metabolites into the cells of tissues with the capacity to metabolize and eliminate xenobiotics.  
The predicted networks with increased association with response to chemicals and drugs 
(xenobiotics) may reflect further this association.  In addition, the association with both 
peptide and the steroid thyroid hormones (regulation of metabolism) and intracellular 
signaling involving both positive and negative regulation of cellular processes, including the 
cell cycle/cell proliferation all suggest an integrated effort at the systemic level to respond to 
toxicity (i.e., inflammatory pathways) and remove naphthalene and the naphthol metabolites 
from the body.  If this biological response to naphthalene exposure is a quantitative or 
continuous trait, then 100‘s, if not 1000s of sequence variants at the DNA and protein level 
may contribute in some small way to the observed biomarker phenotypes.  Here, we may 
have identified only those contributing to the observed phenotypes at a few percent relative 
contributions each.  Nonetheless, a quantitative genetic variation difference between 
individuals has been demonstrated in response to naphthalene exposure and clearance in this 
small, well-defined, and exposed population of individuals. 
The SNP probes on the Affymetrix 250K StyI array used in this study were sparse 
and the coverage of gene was relatively poor.  For example, among 498 SNPs on candidate 
genes, only 9 on Exon (CYP1A2, ARNT2, EPHX1, EPHX2, CYP26B1, GSTM3, CYP4B1), 
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and 87 on Intron, the others were in upstream or downstream.  The sparse probe set may 
leave those SNPs with significant effect size unidentified due to unavailable SNP genotype 
information and reduced statistical association due to the distance from the true quantitative 
SNPs, and, thus, we may miss the more significant SNPs associated with the urine biomarker 
level.  The SNPs statistically associated with these or other phenotypes are polymorphic 
genetic biomarker whose mechanistic basis for the association is inferred and not understood.  
In this context, the relationship between the SNP and biomarker level is unknown and may 
represent either a genetic, epigenetic, or regulatory function connected within a genetic 
sequence or to an intergenic sequence with uncertain function.  These intergenic sequences 
are likely associated with either cis- or trans-related functional sequences.  Poorly understood 
regulatory regions include locus control, enhancer, suppressor, insulator, promoter or intron 
sequence that may alter transcription, translation, including splice variation and creation of 
different enzyme isoforms, etc., or post-translational modification that affect function and 
contribute some size effect on the quantitative phenotype.  Higher density of SNP probe 
array (such as Affymetrix Genome-wide Human Array 6.0 can genotype more than 906,600 
SNPs) can be used to genotype more SNPs in the future study.  Imputation with considerable 
reliability from the HapMap panel (Collins 2009) also could be applied to provide a route to 
testing additional SNPs without further genotyping. 
The selection of candidate genes in this study was limited to genes involved in 
metabolism and toxicokinetics of naphthalene and PAHs, excluding genes on other biological 
processes, such as cell proliferation and differentiation, cell metabolism, regulation of 
physiological states, etc., which may be critical in the level of urine biomarkers.  Candidate 
genes on other pathways than metabolism and toxicokinetics need to be considered in future 
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study.  The predicted networks based on the GWA results in this study can provide new 
candidate genes for future study. 
The sample size was small in this study compared with GWAS case-control study 
aimed to map disease marker.  The small effect size of complex diseases requires larger 
sample size to get enough statistical power due to the ignorance of gen-gene and gene-
environment effect.  It is difficult to identify these interactions in GWAS given the poor 
characterization of environmental exposures in these large, often multi-center/country studies 
(Vlaanderen et al. 2010).  Our study population is well defined in that environment 
characteristics were collected such as quantitative exposure data and workplace factors.  The 
identification of gene-environment interactions as exposure is more prevalent and assessed 
with greater accuracy than in population or hospital-based case-control studies in GWAS.  
Furthermore, intermediate quantitative traits were used instead of binary disease status, 
which are more objective (less misclassification), more informative, and can increase several 
fold in statistical power (Potkin et al. 2009).  Thus, the required sample size could be 
decreased and still achieve sufficient power. 
Population structure issues may exist in this study due to the non-homogeneous 
ethnicity study subjects.  The self-reported ethnicity was not significant during covariate 
determination step, which means the ethnicity could not explain the variation in urine 
biomarker levels.  The qq-plot of P-values of association between urine naphthol levels and 
SNPs didn‘t show significant deviation indicating no population structure in our study 
population.  Principal component analysis (Patterson et al. 2006; Price et al. 2006) could be 
used to correct any potential population stratification in the future study, which has been 
successfully used for GWAS to correct population structure (Price et al. 2006). 
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Measurement errors exist in any analytical analysis and SNP genotyping and calling.  
The true association between a biomarker and exposure can be biased by measurement error.  
The reliability of quantitative urine biomarker and SNP genotyping is required, and the valid 
measurements of covariates are needed as well.  Repeated sampling on individuals will allow 
researchers to compare exposure and biomarker variability within individuals to the 
variability between individuals.   In the future study, repeated sampling of exposure and 
biomarker data on individuals will better capture the true impact of genetic variation on the 
biomarker variability. 
However, this discovery study provides for the generation of new hypotheses to 
investigate the biological functions of potential genetic factors that affect the urine biomarker 
level for systemic exposure.  The biological meanings of SNP associated genes will need to 
be replicated in association study and validated on a genetic and molecular basis.  Candidate 
genes other than metabolism of naphthalene and PAHs should be considered two-stage 
design and replication of the initial findings in follow-up studies can reduce the false-positive 
results and artifacts of the technique (Collins 2009).  However, replication is not easily 
achievable in that the populations are exposed to very different levels (i.e., not many other 
populations with similar levels of environmental exposure) (Vineis et al. 2009).  Ultimately, 
the biological functions have to be validated by genetic and molecular analysis. 
These results call attention to the role of individual genetic variation in exposure 
assessment, and provide a practical method and strategy to investigate the role of individual 
genetic variations in quantitative assessment of biomarker levels in small well-characterized 
worker population.  We provide evidence that the impact of individual genetic differences on 
the measured biomarker levels should not be ignored in exposure assessment and 
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epidemiology studies.  We further show that the systemic exposure levels (metabolite levels 
of xenobiotics) can be used as intermediate quantitative traits when investigating association 
between dose-response relationship and individual susceptibility to disease.  Studies 
including individual genetic markers have potential to provide mechanistic insight into the 
etiology of disease, to identify susceptible subpopulation with respect to exposure, and 
provide useful input in setting exposure limits by taking into account individual susceptibility 
to adverse health effects. 
3.6 Conclusions 
We investigated the association and contribution between SNP variants (as genetic 
markers) and biomarker levels (skin NKAs and urine naphthols) along with other personal 
and workplace factors between JP-8 exposed workers.  In addition, we used MLRMs to 
determine the relative contribution of each of the significant predictors on the observed 
biomarker levels.  One SNP associated gene (AHR) was identified using CGA after 
correction for multiple testing.  Several genes and predicted networks involved thyroid 
hormone related nuclear receptor pathways affect metabolism as well as lipid and fatty acid 
metabolism that may relate to membrane synthesis and/or transport as well as the positive 
and negative regulation of cellular processes critical the potential absorption and clearance of 
naphthol metabolites.  This study and the data present provide the methods and strategy for 
investigation of individual genetic variations and quantitative biomarkers of exposure to be 
used in exposure assessment.  This GWA study may be considered a discovery study that 
identified SNP associated genetic variants that significantly contributed to systemic exposure 
and clearance of naphthalene.  The biological functions of the GWA identified candidate 
variant genes and sequences require functional validation by molecular genetic analysis and 
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replication.  It is imperative that the sources of individual genetic variations will be 
accounted for in future epidemiological and exposure assessment studies that utilize 
biomarkers of exposure and/or effect to shed light on the exposure-disease relationship.  
Studies, including individual genetic markers as variance components, have potential to 
provide mechanistic insight into the etiology of disease, to identify susceptible subpopulation 
with respect to exposure, and provide useful input in setting exposure limits by taking into 
account individual susceptibility to adverse health effects. 
 
   
CHAPTER 4.  DISCUSSION AND CONCLUSIONS 
Current association studies neglect the impact of environmental factors, which may 
change the effect of risk alleles on disease in magnitude and sometimes in direction, 
depending on the environmental circumstances.  On the other hand, current exposure 
assessment studies do not account for individual genetic variations.  We have overlooked the 
effect of gene environment interaction in both association and exposure assessment studies.  
In the studies presented here, I developed methodology to investigate the effect of individual 
genetic variation from the perspective of exposure assessment, and provided information 
about the relative contribution of genetic variation to biomarker levels of naphthalene among 
jet fuel air force workers. 
The biomarkers of naphthalene studied were skin NKAs (Chapter 2) and urinary 
naphthols (Chapter 3).  The skin NKAs were tissue specific and only resulted from dermal 
exposure, while urinary naphthols were results of systemic exposure including both dermal 
and inhalation exposure.  Use of both CGA and GWAS tandem with multiple linear 
regression models allowed to identify significant associated SNPs with both skin and urine 
biomarkers.  The Pratt index computation provided information of the quantitative 
contributions of each factor to the level of the biomarkers that aided in the comparison of the 
relative contributions of SNPs to the other factors in the model.  The pathway and network 
analysis predicted the possible biological functions potentially important in the formation of 
biomarkers in body.  The predicted network analyses provided potential genes for further 
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analysis and validation to understand the impact of individual genetic variation in 
naphthalene exposure assessment. 
4.1 Findings and significance 
The CGA with the selected 35 candidate genes showed that one SNP (rs4852279) 
related to CYP26B1 was significantly associated with the 2NK-adduct level (Chapter 2), and 
one SNP related to AHR was significantly associated with 1NAP level (Chapter 3).  The 
relative contribution of these two SNPs in their own final models was greater than the 
contributions of exposure or personal factors alone, indicating that the effect of individual 
variations in SNPs should not be ignored in exposure assessment.  The contribution of SNP 
rs4852279 (Chapter 2) to skin NKA level may be related to CYP26B1 in the control of RA, 
regulating epidermal proliferation and differentiation, inducing keratinocyte proliferation, 
and inhibiting mRNA and protein expression of suprabasal layer KRT10 (Poumay et al. 
1999).  The variation of rs4852279 related to CYP26B1 may be associated with different 
level of RA in the skin leading to varied level of KRT10, therefore, may affect observed level 
of the skin NKAs in this study.  This shows that individual variations in genes controlling of 
RA, which regulated keratin levels in skin, may lead to varied levels of skin NKAs.  The 
other SNP rs590197 related to AHR (Chapter 3), contributed to 1NAP level, may be 
explained by the role of AHR in the induction of naphthalene metabolizing enzymes, such as 
CYP1A1, CYP2A1, CYP1B1, NQO1 (Nebert et al. 2000).  Upon binding of a ligand, such as 
naphthalene, AHR translocates into the nucleus, where AHR binds of aryl hydrocarbon 
receptor nuclear translocator (ARNT).  The activated AHR/ARNT complex interacts with 
DNA by binding to recognition sequences located in the promoters of genes.  The variation 
in rs590197 related to AHR may result in a variety of differential changes in gene expression 
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of these enzymes and lead to varied levels of 1NAP.  This finding indicated that AHR-
mediated signaling might contribute to individual susceptibility to naphthalene exposure 
among JP-8 exposed workers. 
Based on the GWA and MLRM results, the sum of the relative contribution of all 
SNPs in the final models of both skin NKAs and urinary naphthols were greater than other 
personal or environmental factors included.  Therefore, the effects of individual variations in 
SNPs should be included when predicting biomarker levels in JP-8 exposed workers.  Further, 
I was able to predict 3 networks involving regulation of cellular processes, chemical 
homeostasis, neuron differentiation, and synapse assembly with skin NKAs (Chapter 2), and 
3 networks related to regulation of cellular process, lipid metabolic process, and intracellular 
signaling with urinary naphthols (Chapter 3). 
The first predicted network involves CD47, RPS6KA2, KLF6, and MSRA.  CD47 is 
involved in the increase in intracellular calcium concentration that occurs upon cell adhesion 
to extracellular matrix, and it may play a role in membrane transport and signal transduction 
(Brown and Frazier 2001; Rebres et al. 2001).  KLF6 and RPS6KA2 networks are strongly 
associated with the regulation of cell proliferation and differentiation, including keratinocytes 
and, thus, might affect skin NKA levels.  MSRA carries out the enzymatic reduction of 
methionine sulfoxide to methionine and MSRA genes are differentially expressed in human 
skin (Taungjaruwinai et al. 2009).  RA regulates MSRA expression and their proposed 
functions are to repair oxidative damage to proteins and to restore biological activity.  In the 
second predicted pathway, ADD3 has been identified associated with blood pressure and 
hypertension phenotypes (Bianchi et al. 2005; Seidlerova et al. 2009).  CD47 encodes a 
membrane protein, which may play a role in membrane transport and signal transduction 
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(Brown and Frazier 2001; Rebres et al. 2001).  APOA1 encodes a major protein component 
of high-density lipoprotein (HDL) in plasma, which promotes cholesterol efflux from tissues 
to the liver and intestine for excretion. Two cysteine disulfide bonds are required for ABCA1 
transport of APOA1 and are thus potential sites of adduction (Hozoji et al. 2009).  CAV1 
encodes a scaffolding protein, which is the main component of the caveolae plasma 
membranes found in most cell types.  The CAV1 protein links integrin subunits to the 
tyrosine kinase FYN, an initiating step in coupling integrins to the RAS-ERK pathway and 
promoting cell cycle progression (Wary et al. 1998).  In the third pathway, NRXN1 interacts 
with membranes and epidermal growth factor (EGF) through cysteine rich 6-laminin G-like 
domain calcium mediated receptors and 1-calcium binding EGF domain, which are likely 
targets for electrophile adduction.  NRSN1, a vesicular membrane protein, as well as NRXN1 
and NLGN1 may be predicted to interact through the transcriptional factors ZNF217, AHR, 
and ESR1 and the kinases HDAC1 and HDAC2 through ubiquitin and the histone 
deacetylases.  In the skin, we can speculate that tissue specific relaxation of expression might 
have an effect on membrane transport and/or epidermal keratinocyte differentiation.  SNED1, 
although significant SNP associated gene in the GWA, was not associated with any pathways 
or predicted networks.  SNED1 is involved in the regulation of cell-matrix adhesion and 
calcium ion binding (Strausberg et al. 2002).  Together, NRXN1 and SNED1 appear to be 
independent of any known cellular functions in the skin, but if expressed in the skin might 
represent targets for adduction due to the number of cysteine residues. 
The SNPs and predicted networks for urinary naphthol level are involving critical 
receptors and signaling events that affect thyroid hormone regulation of cell and lipid 
metabolism as well as the regulation of cellular processes, including the cell cycle and cell 
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proliferation (Chapter 3).  These processes might control naphthol transport and clearance by 
controlling the rate of available membrane (cell, Golgi, SER & RER, etc.) required for mass 
movement across membranes for cell transport, metabolism, and elimination.  In the first 
predicted network, THRB and THRA encode proteins that are nuclear hormone receptors for 
triiodothyronine that mediate the biological activities of thyroid hormone (Harvey and 
Williams 2002; Zhu and Cheng).  RXRA and RARB are nuclear receptors that mediate the 
biological effects of retinoids, and retinoic acid-mediated gene activation affecting cell 
growth and differentiation (Ahuja et al. 2003; Khetchoumian et al. 2008).  The HDAC2 
histone deacetylase acts on lysine residues at the N-terminal regions of core histones (de 
Ruijter et al. 2003) and plays an important role in transcriptional regulation, cell cycle 
progression, and development (Senese et al. 2007; Yamaguchi et al. 2010).  The protein 
encoded by FAM5C is highly conserved and predicted to be involved in negative regulation 
of the cell cycle.  The interactions of this predicted network based upon this set of SNP 
variants and their likely associated genes and proteins are primarily associated with cell and 
lipid metabolism and responses to xenobiotic exposure.  The second predicted network also 
identifies THRB, RXRB, and HDAC2 as potential key effector proteins along with PIK3CG.  
PIK3CG is an important modulator of extracellular signals, including those elicited by E-
cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the 
structural and functional integrity of epithelia (Rivard 2009).  Interestingly, the gene is 
located in a commonly deleted segment of chromosome 7q22.3, previously identified in 
myeloid leukemia patients (Kratz et al. 2002).  The third predicted network incorporates 
components of the first two predicted networks, plus the IBTK, an inhibitor of Bruton 
agammaglobulinemia tyrosine kinase.  The protein encoded by this gene binds to BTK and 
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downregulates BTK's kinase activity (Liu et al. 2001).  In addition, the encoded protein 
disrupts BTK-mediated calcium mobilization and indirectly negatively regulates the 
activation of NFKB transcription (Rayet and Gelinas 1999).  The final highly associated 
protein is RELA (p65 NFKB subunit), which involves the main inflammatory pathway.  
NFKB1 or NFKB2 binds to REL, RELA, or RELB, to form the active NFKB complex. 
The predicted pathway and networks showed that the identified SNP associated genes 
are not independent but interact with each other and can work collectively through 
meaningful biological processes to contribute to the biomarker levels.  These identified 
genetic associations need to be replicated and their biological functions will need to be 
validated in the genetic and molecular basis in the future.  Therefore, this study should be 
regarded as a discovery study that generated new information on the biological functions of 
potential genetic factors affecting biomarker levels in the JP-8 exposed workers. 
This study aims to call attention to individual genetic variation in exposure 
assessment, and provide a practical method and strategy to investigate the role of individual 
genetic variations in quantitative assessment of biomarker levels in small well-characterized 
worker population.  It provides evidence that impact of individual genetic differences on the 
measured biomarker levels cannot be ignored in exposure assessment and epidemiology 
studies.  I further show that the systemic exposure levels (metabolite levels of xenobiotics) 
can be used as intermediate quantitative traits when investigating association between dose-
response relationship and individual susceptibility to disease.  Studies including individual 
genetic markers have potential to provide mechanistic insight into the etiology of disease, to 
identify susceptible subpopulation with respect to exposure, and provide useful input in 
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setting exposure limits by taking into account individual susceptibility to adverse health 
effects. 
4.2 Overall limitations and future studies 
As in the case of many quantitative exposure assessment studies, the major limitation 
in this study was the small sample size compared with a typical GWAS case-control study 
aimed to map disease marker.  However, the study population was well defined in that 
specific quantitative environment characteristics were measured (such as dermal and 
inhalation exposure data) and the exposure was prevalent and assessed with a great accuracy.  
Furthermore, intermediate quantitative traits were used instead of binary disease status, 
which is more objective (less misclassification), more informative, and can increase 
statistical power several fold (Potkin et al. 2009a).  Nevertheless, large sample size would 
provide more power with well-defined and quantitative traits. 
Our sample was not homogeneous based on self-reported ethnicity, which potentially 
create a population stratification problem.  The quartile-quartile plots of P-values for 
observed and expected P-values did not show any significant deviation, indicating that our 
results should not be biased.  We also used self-reported ethnicity as a covariate in exposure 
modeling for both skin NKAs and urinary biomarkers.  However, the self-reported ethnicity 
only contributed to skin-keratin adduct (2NKA and TNKA) level, but not to the systemic 
exposure (i.e., urinary naphthol levels).  This indicates that ethnicity may represent the type 
of the skin characteristics, such as skin color differences among our study subjects.  However, 
in the future, we may still need use some methods to correct the possible population structure 
for heterogeneous population.  We could sample a larger homogeneous population or use 
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some methods to correct the possible population structure.  Principal component analysis 
(PCA) with ENGENSTRAT has been used for GWAS for population structure (Patterson et 
al. 2006; Price et al. 2006).  The advantages of PCA include providing the most useful 
description of within-continent genetic variation, insensitive to the number of axes inferred, 
and computationally tractable on a genome-wide scale (Price et al. 2006). 
The density of SNP probe (Affymetrix 250K StyI array) used in this study was sparse 
and the coverage of gene was relatively poor.  The failure to identify other associated SNPs 
in this study may be due to insufficient probes covered in the gene regions.  The sparse probe 
set may leave those SNPs with a great effect size unidentified and miss the more significant 
associated SNPs with biomarker levels.  The selection of candidate genes in this study was 
limited to genes involved in metabolism of naphthalene and PAHs, excluding genes on other 
biological processes, such as cell proliferation and differentiation, cell signaling, regulation 
of physiological states, etc., which may be critical in the level of skin NKAs and urinary 
biomarkers.  In this context, the relationship between the SNP and biomarker level is 
unknown and may represent either a genetic, epigenetic, or regulatory function connected 
within a genetic sequence or to a unknown, but likely closest cis- or trans-related sequence or 
regulatory region (including a locus control, enhancer, suppressor, insulator, promoter or 
intron sequence).  These functional sequences may have a role and alter transcription, 
translation (including splice variation and creation of different enzyme isoforms, etc.) or 
post-translational modification and, thus, affect gene function and contribute some size effect 
on the quantitative phenotype.  Candidate genes on other pathways than metabolism need to 
be considered in future studies.  The predicted networks based on the GWA results in this 
study can provide new candidate genes for future studies.  To improve the density of SNP 
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probe, high density of SNP probe array such as Affymetrix Genome-wide Human Array 6.0 
(genotyping more than 906,600 SNPs) could be used in future studies.  In addition, 
imputation could be applied to provide a route to testing additional SNPs without further 
genotyping.  SNPs can be imputed with considerable reliability from the HapMap panel 
(Collins 2009).  Imputation has the potential to improve the fine mapping resolution in 
candidate regions as well. 
The SNP associated genes and predicted networks need to be replicated and validated.  
A potential strategy is a two-stage design and independent replication of samples to confirm 
study findings (Collins 2009).  However, replication is not easily achievable in that the 
populations are exposed to very different levels (i.e., not many other populations with similar 
levels of environmental exposure) (Vineis et al. 2009).  In this sense, genetic and molecular 
validation may be more practical than replicated epidemiological studies.  Ultimately, only 
independent replication of these studies with increased sample size and/or functional 
validation of the candidate gene allelic variants will provide proof.  For example, the 
relationship between KLF6 and KRT1/KRT10 can be tested using miRNA knockdown of 
KLF6 in human skin tissue constructs and the exposure to relevant exposure levels to 
naphthalene. 
The test association for single SNPs has limited utility and is insufficient to disclose 
the complex genetic structure of many common disease and biomarker levels among exposed 
subjects.  Common diseases often arise from the joint action of multiple loci within a gene or 
joint action of multiple genes within a pathway (Luo et al. 2010).  Although each single SNP 
may confer only a small disease risk, their joint actions are likely to have a significant risk 
effects.  The pathway and network analysis allow us to better understand how these SNPs 
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(either within genes or proximate genes) interaction with each other and function jointly as 
certain biological processes that may be critical to the determination of urine biomarker 
among exposed workers.  In case-control GWAS studies, some analytic methods to combine 
preliminary GWAS statistics to identify genes, alleles, and pathways for deeper 
investigations have been proposed (Cantor et al. 2010) that included pathway analysis of 
GWAS results used to prioritize genes and pathways within a biological context.  Following 
a GWAS, association results can be assigned to pathways and tested in aggregate with 
computational tools and pathway databases.  In GWAS, strong associations have often been 
difficult to interpret because of the location of the SNP in relation to the position and distance 
from flanking genes or within gene poor intergenic regions.  For SNPs in the coding and 
known regulatory regions, assignment is straightforward.  For the other SNPs, rules and 
criteria for assignment should be made and followed, although they should be considered 
arbitrary.  For example, Torkamani et al. 2008 (Torkamani et al. 2008) showed the polygenic 
and multiple-pathway nature of complex disorders, consider the possibility of an SNP 
mapping to multiple genes.  Criteria for assignment included the specific hierarchy for gene 
elements to help with their assignment based upon a scheme for coding > intronic > 5‘ UTR > 
3‘ UTR > 5‘ upstream > 3‘ upstream and non-coding intergenic associations.  Assignment of 
SNPs that are 500 or more kb from a known gene based upon our current and limited 
understanding of cis-and trans relationships in gene regulation and SNPs greater than 500 kb 
were excluded from the analysis.  SNPs were assigned to genes using NCBI Entrez dbSNP 
and Gene and Biomart (http://www.biomart.org/). 
In GWAS, the use of genome-wide significance threshold makes few SNPs exceed 
the stringent statistical requirement and genetic markers that do not equal or exceed this 
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conservative threshold are generally ignored or neglected unless the biological plausibility is 
very strong.  One example is the PPARG variants in type 2 diabetes, which was overlooked 
by four out of five studies (Altshuler et al. 2000; Baranzini et al. 2009).  Classical statistical 
meta-analysis of multiple sclerosis data sets revealed genes with known immunological 
functions (Baranzini et al. 2009).  They hypothesized that certain combinations of genes 
flagged by these markers can be identified if they belong to a common biological pathway.  
They conducted a pathway-oriented analysis of two GWAS in MS that takes into account all 
SNPs with nominal evidence of association (P < 0.05).  Using this approach, they were able 
to enrich for both immunological pathways and for the first time were able to identify 
neurological pathways that had been previously overlooked in meta-analysis studies.  In this 
gene-centered analysis, the true associations with markers that lie in large intergenic regions 
were neglected.  In my study, the use of GWA allowed to rank the significant associated 
SNPs with both skin NKAs and urine biomarkers, and the use of MLRMs including 10 SNPs 
with the lowest P-values provided one way to construct a final exposure model and 
investigate the contributions of multiple SNPs to biomarker levels.  The pathway and 
network analyses of multiple SNPs associated genes in the final models provide one way to 
identify biological processes that may be critical to determine the observed biomarker levels 
among exposed workers, without missing important pathway due to stringent threshold. 
Here, I have focused on genome wide pathway analysis using the interrogated SNPs 
available on the Affymetrix StyI array.  Current genotyping platforms in use select SNP 
templates for analysis based upon their linkage disequilibrium patterns that support the best 
genome coverage of the base-pair positions across the chromosomes rather than coverage of 
genes in particular pathways or networks.  This makes SNP assignments to genes and 
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pathways inherently difficult, but not impossible, in a reiterative approach and strategy as 
described here.  In this context, the SNPs tested were used as genetic markers with no 
inference for the basis for the SNP-phenotype association.  Thus, genetic, epistatic, 
epigenetic, and or non-coding RNA gene regulation interactions were not excluded in 
establishing the predicted networks that may be associated with individual variation and 
biomarker levels observed along with other predictors of naphthalene exposure. 
The measurement errors exist in any analytical analysis and SNP genotyping and 
calling.  The true association between a metabolite and genetic variation can be biased by 
measurement error.  The reliability of quantitative skin adduct biomarkers, urinary 
biomarkers and SNP genotyping is required to achieve a accurate association, and the valid 
measurements of exposure and covariates are needed as well.  In addition, to assess the 
impact of measurement error on the observed association between allele marker and 
metabolite endpoints, a repeated sampling design is necessary (Vlaanderen et al. 2010), 
which allow to compare exposure and biomarker variability within individuals to the 
variability between individuals.  Repeated sampling of exposure and biomarker levels in 
individuals will better capture the true impact of genetic variation on the biomarker 
variability.  In a future study, repeated sampling could be designed to obtain the within- and 
between- individual variability.  Intraclass correlation coefficient can be used as a measure to 
assess the variability of biomarkers and exposure within- and between- individuals.  It 
represents the proportion of the total variance that can be attributed to the between-individual 
variance (Vlaanderen et al. 2010). 
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4.3 Scientific contributions and conclusions 
To my knowledge, they are the first studies in which individual genetic 
polymorphism markers (i.e., SNPs) contributing to quantitative biomarker levels (skin NKAs 
and urine naphthols) measured in exposed workers were investigated using an association 
study tandem with multiple linear regression modeling.  This study provides the methods and 
strategy to investigate the role of individual genetic variations in quantitative assessment of 
biomarker levels in small well-characterized worker population.  Further, this study provides 
evidence that impact of individual genetic differences on the measured biomarker levels 
should not be ignored when investigating factors (personal and environmental) that may 
affect the outcome in epidemiological studies.  Thus, the systemic exposure levels 
(metabolite levels of xenobiotics) can be used as intermediate quantitative traits when 
investigating association between dose-response relationship and individual susceptibility to 
disease.  It is imperative that the sources of individual genetic variations will be accounted 
for in future epidemiological and exposure assessment studies that utilize biomarkers of 
exposure and/or effect to shed light on the exposure-disease relationship.  Studies, which 
include individual genetic markers as variance components, have potential to provide 
mechanistic insight into the etiology of disease, to identify susceptible subpopulation with 
respect to exposure, and provide useful input in setting exposure limits by taking into account 
individual susceptibility to adverse health effects. 
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